Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

CD2_BENIGN_LIPO_SKIN_TRUNK_EXALLC

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data
1. Apply sex-specific rule None	-
2. Check conditions None
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D17.1& Cause of death: ICD-10 — D17.1& 2 out of 7 registries used, show all original rules.	-
4. Check minimum number of events None	-
5. Include endpoints None	-
6. Filter based on genotype QC (FinnGen only) None	-

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: D17
Name in latin: Neoplasma benignum lipomatosum cutis trunci

NAME	CD2_BENIGN_LIPO_SKIN_TRUNK_EXALLC
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D171
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D171
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

Case counts by codes

↥

FinnGen case counts by registry codes:

No upset plot: script not run.

No upset table: script not run.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	5464	3232	2232
Unadjusted period prevalence (%)	1.05	1.10	0.98
Median age at first event (years)	54.59	53.69	55.89

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
4815: Matched controls
48149

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

68.3

323.0

2555

785

D17.1

ICD-10 Finland

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

4503599627370496.0

323.0

4809

QBE99

NOMESCO Finland

Other excision or repair of lesion of skin of trunk

32.4

323.0

540

187

D17.2

ICD-10 Finland

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

14.9

236.4

409

299

115

Kela drug reimbursment

Breast cancer

+∞

234.3

223

D17.9

ICD-10 Finland

Benign lipomatous neoplasm, unspecified

19.7

233.0

361

197

C61

ICD-10 Finland

Malignant neoplasm of prostate

283.4

213.0

216

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

2021.7

211.9

204

PJA12

NOMESCO Finland

Sentinel node biopsy

407.8

197.5

197

130

Kela drug reimbursment

Malignant tumour

+∞

196.2

187

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

177.2

169

D17

ICD-10 Finland

Benign lipomatous neoplasm

15.3

162.3

276

191

H02AB02

ATC

dexamethasone; systemic

15.3

161.8

275

190

D17.0

ICD-10 Finland

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

12.0

158.5

301

267

R22.2

ICD-10 Finland

Localized swelling, mass and lump, trunk

8.0

158.3

378

507

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

+∞

150.8

144

A04AA02

ATC

granisetron; systemic, transdermal

118.9

149.0

161

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

66.0

148.2

172

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

5.9

138.3

412

750

QCE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in upper limb

10.6

134.9

272

271

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

1292.4

129.8

126

116

Kela drug reimbursment

Prostate cancer

+∞

108.7

104

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

101.7

108.5

119

HAC20

NOMESCO Finland

Total mastectomy

180.5

101.7

106

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

330.3

97.3

S18

ICPC

Laceration/cut

1.9

91.8

1959

12710

SPAT1153

SPAT

Removal of sutures

2.0

91.4

1568

9363

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

3.5

90.6

460

1405

QDE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in lower limb

6.8

85.8

227

350

HAB40

NOMESCO Finland

Wedge excision of mammary gland

18.6

82.6

129

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

409.3

81.2

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

+∞

80.4

WF003

NOMESCO Finland

Adjuvant radiotherapy

144.1

80.2

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

140.7

78.2

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

393.7

78.0

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

6.1

77.9

222

378

L03AA13

ATC

pegfilgrastim; parenteral

770.5

77.5

WF002

NOMESCO Finland

Radical radiotherapy

33.0

73.5

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

72.0

L02BA01

ATC

tamoxifen; oral

57.6

72.0

TQW99

NOMESCO Finland

Other minor procedure on skin

4.7

71.5

255

563

L02BG04

ATC

letrozole; oral

8.7

70.3

156

184

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

+∞

68.9

C50.99

ICD-10 Finland

Breast, unspecified

+∞

66.8

L01BC06

ATC

capecitabine; oral

+∞

65.8

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

4.8

65.5

230

499

A03FA01

ATC

metoclopramide; systemic, rectal

2.3

65.3

677

3188

WX110

NOMESCO Finland

Local anesthesy

1.7

64.6

3169

25554

HA1AA

NOMESCO Finland

X-ray mammography

4.6

63.6

233

528

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

48.8

63.5

WX408

NOMESCO Finland

General anesthesy, balanced

1.9

62.3

1152

6882

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

615.9

61.9

S04

ICPC

Lump/swelling localized

2.6

61.9

501

2068

JN4BD

NOMESCO Finland

Extensive body CT

3.5

61.3

306

916

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

9.8

60.8

126

132

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.8

60.8

1283

8008

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

+∞

60.5

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

64.5

60.4

N02BE01

ATC

paracetamol; systemic, rectal

1.9

60.3

3996

34866

D48.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Connective and other soft tissue

6.2

59.5

166

275

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

574.8

57.8

C50

ICD-10 Finland

Malignant neoplasm of breast

564.6

56.7

A04AA55

ATC

palonosetron, combinations; systemic

554.3

55.7

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

+∞

53.2

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

+∞

52.2

QX3AT

NOMESCO Finland

Ultrasound guided biopsy of subcutaneous tissue

29.6

51.9

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

+∞

51.1

WF049

NOMESCO Finland

Radiotherapy of metastasis

+∞

50.1

NAR20

NOMESCO Finland

Complete excision of soft tissue tumour of spine, unspecified

31.8

49.9

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.6

49.3

390

1580

D17.7

ICD-10 Finland

Benign lipomatous neoplasm of other sites

24.5

49.3

X76

ICPC

Malignant neoplasm breast female

252.7

49.1

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

+∞

49.0

L02BB03

ATC

bicalutamide; oral

+∞

48.0

A04AD12

ATC

aprepitant; systemic

164.9

46.9

J01DB01

ATC

cefalexin; oral

1.6

46.0

3753

32824

Y77

ICPC

Malignant neoplasm prostate

101.0

45.8

L03AA14

ATC

lipegfilgrastim; parenteral

451.9

45.3

NK6AN

NOMESCO Finland

Total body bone isotope imaging

21.9

44.4

R23.8

ICD-10 Finland

Other and unspecified skin changes

2.0

44.2

631

3377

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.8

43.2

818

4846

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

+∞

42.8

XX3DW

NOMESCO Finland

Time consuming IT work

2.9

42.1

264

929

GA1BG

NOMESCO Finland

MRI of chest

46.8

41.9

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

411.0

41.2

ZX090

NOMESCO Finland

Other technic of radiotherapy

90.9

40.8

S78

ICPC

Lipoma

7.9

40.7

123

D48.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified

5.9

40.3

116

201

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

+∞

39.6

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

+∞

39.6

A02BC02

ATC

pantoprazole; systemic

1.5

39.5

2846

23635

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

390.6

39.1

B01AB05

ATC

enoxaparin; parenteral

1.6

38.8

1166

7897

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

63.4

38.1

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

380.4

38.1

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

+∞

37.5

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

+∞

37.5

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

+∞

37.5

QAE99

NOMESCO Finland

Other excision or repair surgery of skin and subcutaneous tissue in head and neck

5.9

37.5

107

184

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

22.7

37.4

M01AE01

ATC

ibuprofen; systemic, rectal

1.7

37.0

4190

38335

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

2.9

36.8

230

807

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

+∞

36.5

KE3AT

NOMESCO Finland

Transrectal gold marker implantation in prostate under ultrasound guidance

+∞

36.5

N02AX02

ATC

tramadol; systemic, rectal

1.5

36.1

1816

13853

WZC30

NOMESCO Finland

Teaching

2.1

36.1

453

2289

L72.1

ICD-10 Finland

Trichilemmal cyst

2.4

36.0

320

1380

L03AA02

ATC

filgrastim; parenteral

21.9

35.6

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

+∞

35.5

JN4AD

NOMESCO Finland

Body CT examination

3.3

35.2

187

587

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

349.7

35.0

ZX080

NOMESCO Finland

Image guided radiotherapy

124.3

34.7

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

37.0

34.6

L02AE02

ATC

leuprorelin; implant, parenteral

6.7

34.6

137

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

+∞

34.4

QBA99

NOMESCO Finland

Other local destruction of skin of trunk

10.3

33.7

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

10.4

33.5

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

+∞

33.4

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

+∞

33.4

GA1CG

NOMESCO Finland

Extensive MRI of chest

63.8

33.0

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

329.3

32.9

R03AC02

ATC

salbutamol; inhalant

1.4

32.4

2320

18882

A04AA01

ATC

ondansetron; systemic, rectal

3.5

32.3

157

460

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

+∞

32.3

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

6.1

31.9

149

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

319.1

31.9

NBR20

NOMESCO Finland

Intralesional or marginal excision of soft tissue tumour of shoulder or upper arm

26.1

31.8

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

31.8

2051

16335

M01AH05

ATC

etoricoxib; oral

1.4

31.8

2711

22788

JN4CD

NOMESCO Finland

Very extensive body CT

4.4

31.4

116

267

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

+∞

31.3

ZXA05

NOMESCO Finland

Left side

1.6

31.2

1032

7102

D17.3

ICD-10 Finland

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

21.6

30.8

N03AX16

ATC

pregabalin; oral

1.6

30.3

999

6858

WX402

NOMESCO Finland

General anaesthesia

1.8

30.2

591

3502

XKD00

NOMESCO Finland

Uroflowmetry

1.8

30.1

517

2939

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

4.7

29.9

103

221

UJF32

NOMESCO Finland

Coloscopy

1.6

29.4

1019

7074

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

+∞

29.2

HA013

NOMESCO Finland

Radiotherapy after total ablation of mammary gland

+∞

29.2

XW3AT

NOMESCO Finland

Biopsy of other superficial organ with ultrasound guidance

20.6

29.1

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

40.3

29.0

HAB50

NOMESCO Finland

Partial excision of mammary gland with reconstructive operation

104.0

28.7

ZX070

NOMESCO Finland

Intensity modified radiotherapy

104.0

28.7

HAB99

NOMESCO Finland

Other partial excision of mammary gland

6.5

28.7

116

N63

ICD-10 Finland

Unspecified lump in breast

2.5

28.6

234

964

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

3.9

28.3

118

305

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.4

28.2

1676

13044

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

+∞

28.1

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.5

28.1

1453

10996

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.6

28.1

908

6190

WX002

NOMESCO Finland

Sedation and analgesia

1.6

28.1

820

5452

M54.5

ICD-10 Finland

Low back pain

1.5

27.4

1411

10659

8500/2-C50.9

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS

+∞

27.1

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

+∞

27.1

TKE00

NOMESCO Finland

Needle biopsy of prostate

4.2

26.9

104

251

SPAT1263

SPAT

Sampling

1.4

26.7

1789

14198

J01MA02

ATC

ciprofloxacin; systemic

1.4

26.4

1551

12006

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.6

26.2

203

813

UKC02

NOMESCO Finland

Cystoscopy

1.7

26.2

558

3390

C67.9

ICD-10 Finland

Malignant neoplasm: Bladder, unspecified

+∞

26.1

M01AB05

ATC

diclofenac; systemic, rectal

1.4

26.0

3030

26448

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

3.5

25.8

126

372

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

33.2

25.5

ZXA00

NOMESCO Finland

Right side

1.5

25.3

1078

7805

SAA02

NOMESCO Finland

Basic examination of mouth

1.4

25.2

2796

24131

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

+∞

25.0

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

24.9

1693

13422

L57.0

ICD-10 Finland

Actinic keratosis

2.1

24.9

281

1355

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

24.7

1766

14121

L02BG03

ATC

anastrozole; oral

21.3

24.7

WF004

NOMESCO Finland

Palliative radiotherapy

251.4

24.7

KCD02

NOMESCO Finland

Transurethral resection of bladder

13.1

24.6

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

130.7

24.6

NK1AT

NOMESCO Finland

Muscle biopsy with ultrasound guidance

32.2

24.6

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

15.5

24.5

J01DA01

ATC

[U] cefalexin; systemic

1.4

24.5

2750

23725

M03BX02

ATC

tizanidine; oral

1.4

24.4

2832

24558

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.4

24.2

2526

21510

M79.6

ICD-10 Finland

Pain in limb

1.4

24.1

1536

12015

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.7

24.1

509

3084

8380/3-C54.1

ICD-O-3

Endometrioid adenocarcinoma, NOS, of endometrium

+∞

24.0

8120/3-C67.9

ICD-O-3

Transitional cell carcinoma, NOS, of bladder, NOS

+∞

24.0

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

6.9

23.9

N02AA05

ATC

oxycodone; systemic

1.8

23.9

403

2267

SAA01

NOMESCO Finland

Simple examination of mouth

1.4

23.7

3108

27431

J01FA10

ATC

azithromycin; systemic

1.4

23.7

2499

21281

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

125.6

23.6

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

125.6

23.6

WX702

NOMESCO Finland

Supraglottic ventilation device

2.3

23.5

225

1007

ZZR00

NOMESCO Finland

Flap of skin

8.6

23.5

R22

ICD-10 Finland

Localized swelling, mass and lump of skin and subcutaneous tissue

3.3

23.5

119

363

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

23.3

900

6363

Z51.5

ICD-10 Finland

Palliative care

4.0

23.2

238

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.5

23.1

1037

7571

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.8

23.0

408

2334

TPH04

NOMESCO Finland

Cathetrisation of vein

1.6

22.9

762

5202

C50.31

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor

+∞

22.9

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.8

22.9

417

2409

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.4

22.5

1139

8510

HA4AT

NOMESCO Finland

Labeling mammary gland pathology with ultrasound guidance

8.6

22.3

HAB00

NOMESCO Finland

Excision of lesion of mammary gland

3.4

21.9

109

328

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

+∞

21.9

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

+∞

21.9

NB1CG

NOMESCO Finland

Shoulder and humerus extensive MRI examination with high intensity magnet

3.2

21.8

119

384

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

21.7

1599

12772

A02BC05

ATC

esomeprazole; systemic

1.4

21.6

1706

13782

C44.71

ICD-10 Finland

Basocellular carcinoma of the skin of the lower extremity including the hip

115.5

21.6

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

115.5

21.6

K02.1

ICD-10 Finland

Caries of dentine

1.3

21.5

2431

20789

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

+∞

20.8

L02BG06

ATC

exemestane; oral

+∞

20.8

QCE99

NOMESCO Finland

Other excision or repair of lesion of skin of upper limb

8.3

20.8

B01AB10

ATC

tinzaparin; parenteral

2.3

20.8

193

851

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.3

20.7

1921

15891

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

77.1

20.7

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

210.8

20.6

C90.0

ICD-10 Finland

Multiple myeloma

110.5

20.6

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

30.1

20.5

WX302

NOMESCO Finland

Thoracal epidural anesthesy

2.9

20.5

125

435

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

20.4

1568

12586

NA2CG

NOMESCO Finland

Thoracal spine extensive MRI examination with high intensity magnet

5.5

20.3

110

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

48.2

20.1

R06.0

ICD-10 Finland

Dyspnoea

1.4

20.1

949

6970

M25.5

ICD-10 Finland

Pain in joint

1.4

20.1

1229

9479

HAE10

NOMESCO Finland

Reconstruction of breast using graft or flap

27.1

20.0

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

20.0

1686

13721

P01AB01

ATC

metronidazole; oral, rectal

1.4

19.8

1651

13404

8720/3-C44.5

ICD-O-3

Malignant melanoma, NOS, of skin of trunk

+∞

19.8

C50.82

ICD-10 Finland

Overall malignant tumor of the mammary gland, lobular tumor

+∞

19.8

YJ2VG

NOMESCO Finland

MRI examination of pelvis with high intensity magnet for dose design of radiotherapy

+∞

19.8

8520/3-C50.4

ICD-O-3

Lobular carcinoma, NOS, of upper-outer quadrant of breast

+∞

19.8

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.3

19.7

2263

19286

WX704

NOMESCO Finland

Intubation

2.0

19.7

271

1419

R22.3

ICD-10 Finland

Localized swelling, mass and lump, upper limb

3.2

19.6

106

340

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.7

19.6

452

2800

SPAT1301

SPAT

No procedures

1.4

19.6

1266

9847

S82

ICPC

Naevus/mole

1.7

19.6

476

2994

KEC00

NOMESCO Finland

Retropubic radical prostatectomy

200.7

19.6

N40

ICD-10 Finland

Hyperplasia of prostate

1.5

19.4

667

4576

QX3HE

SPAT

3.7

19.4

232

R07.4

ICD-10 Finland

Chest pain, unspecified

1.4

19.1

1094

8325

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.7

19.1

384

2286

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.0

19.0

251

1294

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.5

18.9

644

4409

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

18.8

2104

17820

8090/3-C44.4

ICD-O-3

Basal cell carcinoma, NOS, of skin of scalp and neck

+∞

18.8

C67.2

ICD-10 Finland

Malignant neoplasm: Lateral wall of bladder

+∞

18.8

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

+∞

18.8

TQW20

NOMESCO Finland

Tatoe

23.8

18.6

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

190.7

18.5

J45.9

ICD-10 Finland

Asthma, unspecified

1.5

18.2

710

5005

ZXC96

NOMESCO Finland

Robot assisted procedure

5.7

18.2

QXE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in uspecified region

11.0

18.2

Z01.2

ICD-10 Finland

Dental examination

1.3

18.1

1699

13995

HA1CG

NOMESCO Finland

Extensive MRI examination of mammary gland with high intensity magnet

8.5

18.1

PJD42

NOMESCO Finland

Excision of axillary lymph nodes

14.4

18.1

M01AC06

ATC

meloxicam; systemic, rectal

1.3

18.0

1586

12940

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

17.9

1221

9556

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.2

17.8

178

815

D48.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other specified sites

7.1

17.8

A02BC03

ATC

lansoprazole; oral

1.4

17.8

1198

9359

8720/3-C44.9

ICD-O-3

Malignant melanoma, NOS, of skin, NOS

+∞

17.7

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

95.4

17.6

128

Kela drug reimbursment

Cancers of female genital organs

180.6

17.5

N03AX12

ATC

gabapentin; oral

1.5

17.2

627

4351

J01AA02

ATC

doxycycline; systemic

1.3

17.1

3482

31903

H02AB06

ATC

prednisolone; systemic

1.3

17.1

1894

15943

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

31.6

17.0

C44.61

ICD-10 Finland

Basocellular carcinoma of the skin of the upper extremity including the shoulder

50.2

17.0

D48.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Breast

3.5

16.9

223

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.9

16.9

261

1426

R74.8

ICD-10 Finland

Abnormal levels of other serum enzymes

2.6

16.8

127

504

D41.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bladder

8.1

16.7

R22.1

ICD-10 Finland

Localized swelling, mass and lump, neck

2.4

16.7

144

615

8312/3-C64.9

ICD-O-3

Renal cell carcinoma, NOS, of kidney, NOS

+∞

16.7

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

+∞

16.7

308

Kela drug reimbursment

Alprostadil, sildenafil and combination product containing aviptadil and phentolamine

15.1

16.6

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

90.4

16.6

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

90.4

16.6

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.6

16.5

502

3339

R50.9

ICD-10 Finland

Fever, unspecified

1.6

16.5

435

2790

D22.5

ICD-10 Finland

Melanocytic naevi of trunk

2.1

16.5

198

983

C43.50

ICD-10 Finland

Malignant melanoma of the torso without histology

170.5

16.5

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

16.5

2339

20332

G04CB01

ATC

finasteride; oral (testosterone-5-alpha reductase inhibitors)

1.7

16.5

329

1953

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.4

16.3

1135

8895

D21.1

ICD-10 Finland

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

4.6

16.3

123

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.5

16.3

606

4222

M02AA07

ATC

piroxicam; topical

1.3

16.2

1500

12276

QBE15

NOMESCO Finland

Excision of other superficial lesion of skin of trunk

11.7

16.0

WZA90

NOMESCO Finland

Other doctors statement

1.4

16.0

903

6825

R01AD09

ATC

mometasone; nasal

1.3

16.0

1892

16025

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

2.3

15.9

143

621

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.3

15.9

2369

20691

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

15.9

1556

12834

L17

ICPC

Foot/toe symptom/complaint

1.4

15.8

989

7609

8090/3-C44.6

ICD-O-3

Basal cell carcinoma, NOS, of skin of upper limb and shoulder

+∞

15.6

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

+∞

15.6

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

+∞

15.6

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

+∞

15.6

C20.92

ICD-10 Finland

Malignant tumor of the rectum carcinoma of the adenoma

+∞

15.6

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.5

15.6

563

3894

Z51.0

ICD-10 Finland

Radiotherapy session

85.3

15.6

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

160.5

15.5

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

160.5

15.5

A02BC01

ATC

omeprazole; systemic

1.4

15.5

1073

8392

SPAT1254

SPAT

Administration of medicine

1.5

15.2

503

3413

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

1.9

15.2

237

1300

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

2.7

15.2

100

369

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.5

15.1

573

4003

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.5

15.1

656

4715

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

3.4

15.1

213

D70.82

ICD-10 Finland

Drug-induced neutropenia

7.8

15.0

QBE00

NOMESCO Finland

Excision of loose skin or fold of skin from trunk

6.3

15.0

R06AE07

ATC

cetirizine; oral

1.3

14.9

1759

14850

HA6BA

NOMESCO Finland

Breast tomosynthesis specimen

12.4

14.8

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.6

14.7

398

2572

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

18.4

14.7

XQ845

NOMESCO Finland

Dermatoscopy

4.7

14.7

105

A06AC01

ATC

ispaghula (psylla seeds); oral

1.4

14.6

928

7146

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

+∞

14.6

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

+∞

14.6

M54.4

ICD-10 Finland

Lumbago with sciatica

1.4

14.5

670

4869

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

2.3

14.5

131

571

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.3

14.5

1979

17010

EP1CG

NOMESCO Finland

Extensive MRI examination of soft tissue of neck with high intesity magnet

4.7

14.5

102

PJW99

NOMESCO Finland

Other operation on lymphatic system

150.4

14.5

E04.2

ICD-10 Finland

Nontoxic multinodular goitre

2.1

14.5

155

735

ZZR10

NOMESCO Finland

Flap of skin and muscle

10.9

14.5

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

2.0

14.4

175

871

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.4

14.4

662

4810

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.7

14.4

279

1642

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.4

14.3

844

6412

S29

ICPC

Skin symptom/complaint other

1.5

14.2

606

4339

TPH07

NOMESCO Finland

Cathetrisation of artery

1.7

14.2

304

1844

S21

ICPC

Skin texture symptom/complaint

1.5

14.1

443

2968

M03BC01

ATC

orphenadrine (citrate); systemic

1.4

14.0

980

7656

L03

ICPC

Low back symptom/complaint

1.4

14.0

942

7317

R22.0

ICD-10 Finland

Localized swelling, mass and lump, head

2.4

14.0

113

468

M03BC51

ATC

orphenadrine, combinations; systemic

1.3

13.9

1175

9452

SPAT1211

SPAT

Application of soft bandage

1.7

13.9

318

1968

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

13.8

267

1570

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.5

13.7

561

3979

NFR20

NOMESCO Finland

Incomplete excision of soft tissue tumour of hip or thigh

10.4

13.7

L15

ICPC

Knee symptom/complaint

1.4

13.7

818

6225

R22.4

ICD-10 Finland

Localized swelling, mass and lump, lower limb

2.6

13.6

100

391

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.3

13.6

1104

8824

L01CA04

ATC

vinorelbine; systemic

+∞

13.5

1CD02

NOMESCO Finland

+∞

13.5

L08

ICPC

Shoulder symptom/complaint

1.4

13.5

751

5644

M70.6

ICD-10 Finland

Trochanteric bursitis

1.5

13.5

473

3250

I97.2

ICD-10 Finland

Postmastectomy lymphoedema syndrome

140.4

13.4

QBA10

NOMESCO Finland

Incision of skin of trunk

3.9

13.4

139

UJD02

NOMESCO Finland

Gastroscopy

1.9

13.4

185

972

M01AX05

ATC

glucosamine; oral

1.4

13.4

761

5741

WX725

NOMESCO Finland

Noninvasive ventilation

2.0

13.4

165

827

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.3

13.4

1706

14490

J01MA12

ATC

levofloxacin; systemic

1.4

13.4

605

4381

S15

ICPC

Foreign body in skin

1.8

13.3

219

1226

R03BA05

ATC

fluticasone; inhalant

1.4

13.3

700

5212

J01CA04

ATC

amoxicillin; systemic

1.3

13.2

3490

32367

J01FA06

ATC

roxithromycin; oral

1.3

13.2

1654

14016

S79

ICPC

Neoplasm skin benign/unspecified

3.1

13.1

237

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.5

13.1

516

3631

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.4

13.1

877

6800

K03.64

ICD-10 Finland

Dental calculus supragingival

1.3

13.0

1091

8753

SPAT1310

SPAT

Counselling related to known health issue

1.3

12.9

1249

10218

G47.3

ICD-10 Finland

Sleep apnoea

1.4

12.9

880

6839

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.4

12.9

780

5943

E88.2

ICD-10 Finland

Lipomatosis, not elsewhere classified

13.0

12.9

M01AX17

ATC

nimesulide; oral

1.3

12.9

988

7820

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

12.8

2024

17620

2140A

ICD-9 Finland

Lipoma, Skin and subcutaneous tissue of face

5.1

12.7

ZXC50

NOMESCO Finland

Cryotherapy

2.8

12.5

291

R01AD08

ATC

fluticasone; nasal

1.3

12.5

1141

9251

G04CA02

ATC

tamsulosin; oral

1.4

12.5

676

5053

C77.0

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck

+∞

12.5

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

+∞

12.5

Z85.3

ICD-10 Finland

Personal history of malignant neoplasm of breast

+∞

12.5

C50.00

ICD-10 Finland

Malignant tumor of nipple and areola, no histological veryfication

+∞

12.5

XX1XN

NOMESCO Finland

Other isotope examination

+∞

12.5

C18.00

ICD-10 Finland

Malignant tumor of the caecum without histology

+∞

12.5

153

Kela drug reimbursment

Lenalidomid

+∞

12.5

WF001

NOMESCO Finland

Preoperative radiotherapy

+∞

12.5

8130/2-C67.9

ICD-O-3

Papillary urothelial carcinoma, non-invasive of bladder, NOS

+∞

12.5

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

+∞

12.5

8097/3-C44.9

ICD-O-3

Basal cell carcinoma, nodular of skin, NOS

+∞

12.5

8500/3-C50.2

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast

+∞

12.5

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

+∞

12.5

J02AC01

ATC

fluconazole; systemic

1.3

12.5

1597

13540

SPAT1260

SPAT

Consultation of another employee

1.4

12.5

674

5037

J05AB01

ATC

aciclovir; systemic

1.4

12.4

778

5958

A79

ICPC

Malignancy NOS

20.1

12.4

C43.52

ICD-10 Finland

Malignant melanoma on the torso: 'superficial spreading' type

130.3

12.4

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.4

12.4

646

4797

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.4

12.4

100

415

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.6

12.4

331

2130

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.0

12.4

160

822

QDE99

NOMESCO Finland

Other excision or repair of lesion of skin of lower limb

4.1

12.3

116

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

1.9

12.3

166

867

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.3

12.3

1599

13576

A03

ICPC

Fever

1.4

12.3

549

3961

R02

ICPC

Shortness of breath/dyspnoea

1.5

12.3

434

2986

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.5

12.2

425

2912

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

2.5

12.2

384

R03DC03

ATC

montelukast; oral

1.4

12.2

626

4637

ZX120

NOMESCO Finland

Intravenous

1.7

12.1

239

1415

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

7.7

12.1

M01AE02

ATC

naproxen; oral, rectal

1.2

12.1

2370

21098

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

4.7

12.1

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.3

12.0

110

487

SDA02

NOMESCO Finland

Parodonthologic therapy

1.3

12.0

1300

10775

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.5

12.0

446

3099

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.0

12.0

157

812

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

11.9

1122

9132

JN3AD

NOMESCO Finland

Abdominal CT examination

1.7

11.9

242

1446

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.6

11.9

304

1934

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

3.8

11.9

130

R60.0

ICD-10 Finland

Localized oedema

1.5

11.8

379

2552

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.6

11.8

274

1703

L01

ICPC

Neck symptom/complaint

1.4

11.7

527

3805

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.4

11.7

606

4492

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.4

11.7

735

5634

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

1.3

11.7

1487

12575

R01AD12

ATC

fluticasone furoate; nasal

1.3

11.7

1166

9560

SPAT1312

SPAT

General health counselling

1.3

11.6

1212

9994

R51.80

ICD-10 Finland

Headache

1.4

11.6

537

3899

R05

ICPC

Cough

1.3

11.6

829

6480

SPAT1081

SPAT

Cardiorespiratory global assessment

1.8

11.6

215

1252

JN5PN

NOMESCO Finland

Isotope imaging of secondary neoplasms of thyroid origin

+∞

11.5

C43.72

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip: 'superficial spreading' type

+∞

11.5

C50.89

ICD-10 Finland

Overall malignant tumor of the mammary gland, other or undeterminated histology

+∞

11.5

C50.19

ICD-10 Finland

Malignant tumor of the central part of the mammary gland, other or undeterminated histology

+∞

11.5

L04AX04

ATC

lenalidomide; oral

+∞

11.5

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

+∞

11.5

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

+∞

11.5

163

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

11.5

C43.59

ICD-10 Finland

Malignant melanoma of the trunk other or unspecified histology

120.3

11.4

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

120.3

11.4

R31

ICD-10 Finland

Unspecified haematuria

1.6

11.4

293

1871

L82

ICD-10 Finland

Seborrhoeic keratosis

1.4

11.4

553

4050

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.3

11.3

1075

8749

M67.4

ICD-10 Finland

Ganglion

1.7

11.3

250

1533

R42

ICD-10 Finland

Dizziness and giddiness

1.3

11.3

787

6125

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.5

11.3

364

2452

L02

ICPC

Back symptom/complaint

1.6

11.2

323

2120

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.7

11.2

242

1473

N05CF01

ATC

zopiclone; oral

1.3

11.1

1170

9647

J01EA01

ATC

trimethoprim; systemic

1.3

11.1

885

7026

SDA01

NOMESCO Finland

Simple parodonthologic therapy

1.3

11.1

965

7760

WX320

NOMESCO Finland

Spinalanesthesy

1.3

11.0

855

6758

K07.60

ICD-10 Finland

Snapping jaw

1.8

11.0

184

1035

A02BA02

ATC

ranitidine; systemic

1.3

11.0

735

5686

KMAK

NOMESCO Finland

1.2

11.0

2176

19315

D23.5

ICD-10 Finland

Benign neoplasm: Skin of trunk

2.5

11.0

329

HAE05

NOMESCO Finland

Reconstruction of breast using soft tissue and prosthesis

43.4

10.9

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

3.9

10.8

111

DHB00

NOMESCO Finland

Excision of lesion of external nose

6.9

10.8

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

2.9

10.8

217

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.8

10.8

173

963

HAD30

NOMESCO Finland

Reduction mammoplasty with transposition of areola

2.2

10.8

106

486

G44.2

ICD-10 Finland

Tension-type headache

1.4

10.8

507

3694

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

1.7

10.7

219

1313

D01

ICPC

Abdominal pain/cramps general

1.5

10.7

372

2546

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.4

10.7

498

3618

SPAT1141

SPAT

Excision of skin or mucous membrane lesion

1.9

10.7

156

838

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

2.8

10.7

242

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.6

10.6

283

1820

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

60.1

10.6

D24

ICD-10 Finland

Benign neoplasm of breast

2.6

10.5

285

D22.9

ICD-10 Finland

Melanocytic naevi, unspecified

2.0

10.5

137

708

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.7

10.5

215

1290

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.4

10.5

570

4258

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

2.4

10.4

376

GE1CG

NOMESCO Finland

Extensive MRI examination of heart and mediastinum with high intensity magnet

110.2

10.4

C73

ICD-10 Finland

Malignant neoplasm of thyroid gland

110.2

10.4

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

+∞

10.4

L02BX02

ATC

degarelix; parenteral

+∞

10.4

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

+∞

10.4

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

+∞

10.4

ZX095

NOMESCO Finland

Combined chemoradiotherapy

+∞

10.4

C44.81

ICD-10 Finland

Overall basocellular carcinoma of the skin

+∞

10.4

PJD71

NOMESCO Finland

Extended sparing excision of cervical lymph nodes

+∞

10.4

L02BB04

ATC

enzalutamide; oral

+∞

10.4

C17.9

ICD-10 Finland

Malignant neoplasm: Small intestine, unspecified

+∞

10.4

WB133

NOMESCO Finland

Very demanding adjuvant cytostatic therapy

+∞

10.4

C18.99

ICD-10 Finland

Malignant tumor in unspecified location in the colon other or unspecified histology

+∞

10.4

C82.1

ICD-10 Finland

Follicular lymphoma grade II

+∞

10.4

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.3

10.4

809

6394

M01AH01

ATC

celecoxib; oral (coxibs)

1.3

10.3

701

5428

N06AX11

ATC

mirtazapine; oral

1.3

10.3

1219

10185

UJF30

NOMESCO Finland

Ileoscopy through colon

1.5

10.3

341

2315

S54

ICPC

Skin, Repair/fix-suture/cast/prosth device

2.1

10.3

113

546

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.6

10.3

267

KCD05

NOMESCO Finland

Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)

18.8

10.2

XW000

NOMESCO Finland

Bone marrow biopsy

2.2

10.2

103

479

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

23.4

10.2

R03AK07

ATC

formoterol and budesonide; inhalant

1.3

10.2

725

5652

SPAT1249

SPAT

Treatment-related counselling outside office

1.2

10.0

1558

13426

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.3

10.0

747

5863

L16

ICPC

Ankle symptom/complaint

1.5

10.0

365

2528

R03BA02

ATC

budesonide; inhalant

1.3

10.0

656

5051

C05AA08

ATC

fluocortolone; rectal, topical

1.4

10.0

550

4114

E66.8

ICD-10 Finland

Other obesity

1.7

10.0

207

1249

ZSH00

NOMESCO Finland

Procedure related to previous procedure classified in chapter H

40.1

10.0

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.5

9.9

344

2357

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.4

9.9

451

3262

WW500

NOMESCO Finland

Blood transfusion

2.5

9.8

316

WX290

NOMESCO Finland

Other blockade of nerve

1.2

9.8

1722

15026

B02AA02

ATC

tranexamic acid; systemic

1.4

9.8

528

3938

ZZQ00

NOMESCO Finland

Free microvascular graft of skin

26.1

9.8

Z00.0

ICD-10 Finland

General medical examination

1.3

9.8

655

5061

R74

ICPC

Upper respiratory infection acute

1.3

9.7

1032

8501

XJH00

NOMESCO Finland

Transanal ultrasonography

1.8

9.7

158

886

S77

ICPC

Malignant neoplasm of skin

13.4

9.7

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.4

9.6

438

3170

C44.11

ICD-10 Finland

Basocellular carcinoma of the skin of the eyelids including the corner of the eye

55.1

9.6

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

55.1

9.6

M54.6

ICD-10 Finland

Pain in thoracic spine

1.6

9.6

250

1606

S10

ICPC

Boil/carbuncle

1.7

9.5

194

1165

HA1BG

NOMESCO Finland

MRI examination of mammary gland with high intensity magnet

15.0

9.5

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

1.5

9.5

347

2403

A07AA02

ATC

nystatin; oral

1.7

9.5

197

1191

R05

ICD-10 Finland

Cough

1.3

9.4

700

5493

PJD54

NOMESCO Finland

Block dissection of iliac lymph nodes

100.2

9.4

L12

ICPC

Hand/finger symptom/complaint

1.4

9.4

514

3842

Z00.8

ICD-10 Finland

Other general examinations

1.6

9.4

251

1617

M48.0

ICD-10 Finland

Spinal stenosis

1.4

9.4

421

3039

C44.62

ICD-10 Finland

Spinocellular carcinoma of the skin of the upper extremity including the shoulder

30.1

9.4

D21.3

ICD-10 Finland

Benign neoplasm: Connective and other soft tissue of thorax

17.5

9.4

R4110

NOMESCO Finland

Physiotherapy

1.3

9.4

881

7137

8380/3-C54.9

ICD-O-3

Endometrioid adenocarcinoma, NOS, of corpus uteri

+∞

9.4

FM1FN

NOMESCO Finland

Heart function isotope examination

+∞

9.4

329

Kela drug reimbursment

Lenalidomide

+∞

9.4

C50.10

ICD-10 Finland

Malignant tumor of the central part of the mammary gland, no histological veryfication

+∞

9.4

8140/3-C19.9

ICD-O-3

Adenocarcinoma, NOS, of rectosigmoid junction

+∞

9.4

8720/3-C44.6

ICD-O-3

Malignant melanoma, NOS, of skin of upper limb and shoulder

+∞

9.4

C83.00

ICD-10 Finland

Lymphocytic lymphoma

+∞

9.4

C82.01

ICD-10 Finland

Follicular nodular lymphoma, grade I

+∞

9.4

C44.10

ICD-10 Finland

Malignant tumor of the skin of the eyelids including the corner of the eye without histology

+∞

9.4

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.4

9.4

396

2825

ZX112

NOMESCO Finland

Subcutaneous

3.9

9.4

KAD01

NOMESCO Finland

Percutaneous endoscopic partial nephrectomy

12.3

9.3

R01BA52

ATC

pseudoephedrine, combinations; oral

1.2

9.3

1248

10561

D23.9

ICD-10 Finland

Benign neoplasm: Skin, unspecified

2.3

9.3

346

N06AX21

ATC

duloxetine; oral

1.4

9.3

396

2830

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.5

9.3

268

1764

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.5

9.2

327

2252

R05FA02

ATC

opium derivatives and expectorants; systemic

1.2

9.2

1589

13814

BAA60

NOMESCO Finland

Total thyroidectomy

2.3

9.2

340

D01BA02

ATC

terbinafine; oral; topical

1.3

9.2

955

7835

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

5.2

9.2

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

6.0

9.2

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

1.4

9.2

462

3404

KAD00

NOMESCO Finland

Partial nephrectomy

13.7

9.2

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.6

9.1

248

1607

X58

ICD-10 Finland

Exposure to other specified factors

1.4

9.1

490

3650

R21

ICPC

Throat symptom/complaint

1.3

9.1

661

5170

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.3

9.1

1001

8276

HA1DG

NOMESCO Finland

Very extensive MRI examination of mammary gland with high intensity magnet

11.5

9.0

G04CA01

ATC

alfuzosin; oral

1.5

9.0

353

2481

J01MA14

ATC

moxifloxacin; systemic

1.5

9.0

291

1962

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.5

9.0

336

2339

R53

ICD-10 Finland

Malaise and fatigue

1.3

9.0

703

5550

JN6AD

NOMESCO Finland

CT of torso and neck

5.3

9.0

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

1.7

9.0

172

1014

N05CF02

ATC

zolpidem; oral

1.3

9.0

650

5077

TKE10

NOMESCO Finland

Puncture of prostate

36.7

9.0

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.3

9.0

616

4772

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.2

9.0

404

QWD00

NOMESCO Finland

Reoperation for superficial haemorrhage in surgery of skin

6.5

8.9

Z31.5

ICD-10 Finland

Genetic counselling

1.8

8.9

136

745

R96

ICPC

Asthma

1.5

8.9

321

2217

R07.3

ICD-10 Finland

Other chest pain

1.5

8.9

331

2306

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

1.8

8.9

143

798

JAA10

NOMESCO Finland

Excision of lesion of abdominal wall

12.5

8.8

X59

ICD-10 Finland

Exposure to unspecified factor

1.3

8.8

657

5153

GD1AD

NOMESCO Finland

Thorax CT examination

2.0

8.8

115

596

A06AH03

ATC

naloxegol; oral

6.8

8.8

N62

ICD-10 Finland

Hypertrophy of breast

1.8

8.8

137

757

WX720

NOMESCO Finland

Own respiration

1.8

8.8

141

788

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.4

8.7

300

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.5

8.7

260

1724

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.3

8.7

902

7397

M02AA10

ATC

ketoprofen; topical

1.3

8.7

607

4715

L05

ICPC

Flank/axilla symptom/complaint

1.7

8.7

189

1159

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.4

8.6

389

2811

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.4

8.6

466

3478

A02BC04

ATC

rabeprazole; oral

1.5

8.6

310

2142

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.2

8.5

369

GD6AD

NOMESCO Finland

CT of chest and neck

16.3

8.5

L02AE04

ATC

triptorelin; parenteral

16.3

8.5

XQ800

NOMESCO Finland

Prick test

1.5

8.5

266

1784

C08CA01

ATC

amlodipine; oral

1.2

8.5

1297

11115

R03BA08

ATC

ciclesonide; inhalant

1.5

8.5

296

2032

GA1DG

NOMESCO Finland

Very extensive MRI of chest

27.5

8.5

9732/3-C42.1

ICD-O-3

Plasma cell myeloma of bone marrow

27.5

8.5

KAC11

NOMESCO Finland

Total nephrectomy with capsule, transcutaneous

20.0

8.5

ZXC15

NOMESCO Finland

Use of photodynamic technique

4.5

8.4

C09CA01

ATC

losartan; oral

1.3

8.4

890

7313

QAE00

NOMESCO Finland

Excision of loose skin or fold of skin from head and neck

7.3

8.4

KED22

NOMESCO Finland

Transurethral resection of prostate

1.8

8.4

145

829

PJD81

NOMESCO Finland

Excision of lymph nodes from upper part of neck

90.2

8.4

S59

ICPC

Skin, Other therap proced/minor surg NEC

2.9

8.3

165

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

8.3

2878

26659

M54.2

ICD-10 Finland

Cervicalgia

1.5

8.3

259

1733

17402

ICD-8 Finland

Malignant neoplasm of breast, Glandulae

+∞

8.3

C50.93

ICD-10 Finland

Malignant tumor in other specified localization in mammary gland other or unspecified histology

+∞

8.3

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

+∞

8.3

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

+∞

8.3

C15.5

ICD-10 Finland

Malignant neoplasm: Lower third of oesophagus

+∞

8.3

C50.12

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,lobular tumor

+∞

8.3

C50.92

ICD-10 Finland

Malignant tumor in another specified localization in lobular gland, lobular tumor

+∞

8.3

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

+∞

8.3

C67.0

ICD-10 Finland

Malignant neoplasm: Trigone of bladder

+∞

8.3

C19

ICD-10 Finland

Malignant neoplasm of rectosigmoid junction

+∞

8.3

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

+∞

8.3

8850/3-C49.6

ICD-O-3

Liposarcoma, NOS, of connective, Subcutaneous and other soft tissues of trunk, NOS

+∞

8.3

C50.20

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication

+∞

8.3

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

+∞

8.3

8140/3-C34.3

ICD-O-3

Adenocarcinoma, NOS, of lower lobe, lung

+∞

8.3

C43.39

ICD-10 Finland

Malignant melanoma of another or unspecified part of the face other or unspecified histology

+∞

8.3

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

+∞

8.3

SPAT1325

SPAT

Vaccination

1.2

8.3

1233

10527

Z48.0

ICD-10 Finland

Attention to surgical dressings and sutures

1.9

8.3

119

638

SPAT1285

SPAT

Provision of consultation response

1.6

8.3

197

1235

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.4

8.3

349

2489

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.4

8.3

335

2369

J01FF01

ATC

clindamycin; systemic

1.2

8.3

1018

8513

WX199

NOMESCO Finland

Other local analgesia

2.1

8.3

406

D40.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Prostate

4.3

8.3

Z71.8

ICD-10 Finland

Other specified counselling

1.3

8.3

841

6875

R05FB02

ATC

cough suppressants and expectorants

1.2

8.2

1488

12968

L14

ICPC

Leg/thigh symptom/complaint

1.5

8.2

250

1665

DFF00

NOMESCO Finland

Pure tone audiometry

1.5

8.2

302

2098

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.4

8.1

406

2985

XW1AT

NOMESCO Finland

Biopsy from other organ close to skin with ultrasound quidance

5.1

8.1

-1

NOMESCO Finland

1.2

8.1

1255

10757

D22

ICD-10 Finland

Melanocytic naevi

1.8

8.1

133

749

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.3

8.1

953

7929

C44.21

ICD-10 Finland

Basocellular carcinoma of the skin of the outer ear and the outer ear canal

33.4

8.1

NB1BG

NOMESCO Finland

Shoulder and humerus MRI examination with high intensity magnet

2.1

8.1

407

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

4.4

8.0

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.7

8.0

159

949

SPAT1262

SPAT

Handing over of treatment supplies

1.3

8.0

639

5059

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.4

8.0

424

3151

GAE06

NOMESCO Finland

Excision of lesion of chest wall

22.0

8.0

UJH02

NOMESCO Finland

Anoscopy

1.7

8.0

150

880

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.2

8.0

968

8078

J01FA09

ATC

clarithromycin; systemic

1.2

8.0

1232

10555

Z80.3

ICD-10 Finland

Family history of malignant neoplasm of breast

3.2

8.0

122

C03CA01

ATC

furosemide; systemic

1.3

7.9

857

7054

SCA01

NOMESCO Finland

Simple analysis and advice of nutrition with regard to dentistry

1.2

7.9

989

8282

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.4

7.9

357

2581

L02AE03

ATC

goserelin; implant

4.0

7.8

ACC51

NOMESCO Finland

Release of median nerve

1.5

7.8

282

1951

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.4

7.8

417

3103

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.4

7.8

366

2664

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

3.2

7.8

119

HWD00

NOMESCO Finland

Reoperation for deep haemorrhage in surgery of mammary gland

6.9

7.8

Z71.9

ICD-10 Finland

Counselling, unspecified

1.6

7.7

199

1277

GD1CG

NOMESCO Finland

Extensive examination of lungs and pleura with high intensity magnet

15.0

7.7

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

2.0

7.7

442

SPAT1283

SPAT

Restricted health certificate

1.3

7.7

589

4635

JAH01

NOMESCO Finland

Laparoscopy

1.8

7.7

135

779

D82

ICPC

Teeth/gum disease

1.2

7.7

1311

11345

K30

ICD-10 Finland

Functional dyspepsia

1.4

7.7

366

2672

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.3

7.7

307

M04AA01

ATC

allopurinol; systemic

1.4

7.7

371

2715

SPAT1104

SPAT

Monitoring of emergency patient

1.5

7.6

218

1432

R03AC03

ATC

terbutaline; inhalant

1.3

7.6

507

3906

D23.6

ICD-10 Finland

Benign neoplasm: Skin of upper limb, including shoulder

3.6

7.6

X21

ICPC

Breast sympt/compl female other

2.4

7.6

258

R19.0

ICD-10 Finland

Intra-abdominal and pelvic swelling, mass and lump

2.3

7.6

289

D19

ICPC

Teeth/gum symptom/complaint

1.2

7.6

990

8330

HA4ST

NOMESCO Finland

Labeling mammary gland pathology with sterotactic guidance

11.8

7.6

QB9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in torso, unspecified

5.1

7.5

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.4

7.5

407

3039

R06AX27

ATC

desloratadine; oral

1.2

7.5

1005

8478

M05BX04

ATC

denosumab; parenteral

1.8

7.4

116

644

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

7.4

114

630

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

80.2

7.4

C43.62

ICD-10 Finland

Malignant melanoma of upper extremity including shoulder: 'superficial spreading' type

80.2

7.4

QX1BG

NOMESCO Finland

80.2

7.4

KCC10

NOMESCO Finland

Cystoprostatectomy

80.2

7.4

TJF80

NOMESCO Finland

Ostomy education

5.0

7.4

NG1CG

NOMESCO Finland

Knee and lower leg extensive MRI examination with high intensity magnet

2.1

7.4

375

KAC10

NOMESCO Finland

Total nephrectomy with capsule

7.6

7.4

JN2CG

NOMESCO Finland

Extensive MRI examination of lower part of abdoment with high intensity magnet

2.9

7.4

151

XQ848

NOMESCO Finland

Dermatological photography

2.2

7.4

333

QBJ00

NOMESCO Finland

Liposuction in trunk

5.6

7.4

R33

ICD-10 Finland

Retention of urine

1.6

7.3

199

1291

R52.9

ICD-10 Finland

Pain, unspecified

1.4

7.3

287

2020

N92.0

ICD-10 Finland

Excessive and frequent menstruation with regular cycle

1.4

7.3

305

2172

YG1CD

NOMESCO Finland

Very extensive CT examination of thorax for dose design of radiotherapy

+∞

7.3

C20

ICD-10 Finland

Malignant neoplasm of rectum

+∞

7.3

C50.59

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, other or undeterminated histology

+∞

7.3

HAC25

NOMESCO Finland

Radical mastectomy

+∞

7.3

C92.0

ICD-10 Finland

Acute myeloblastic leukaemia [AML]

+∞

7.3

WB223

NOMESCO Finland

Demanding adjuvant hormone therapy of malignancy

+∞

7.3

C83.1

ICD-10 Finland

Mantle cell lymphoma

+∞

7.3

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

+∞

7.3

C64

ICD-10 Finland

Malignant neoplasm of kidney, except renal pelvis

+∞

7.3

C18.40

ICD-10 Finland

Malignant tumor of the transverse colon without histology

+∞

7.3

L01CB01

ATC

etoposide; systemic

+∞

7.3

Z08.8

ICD-10 Finland

Follow-up examination after other treatment for malignant neoplasm

+∞

7.3

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

+∞

7.3

8140/3-C18.0

ICD-O-3

Adenocarcinoma, NOS, of cecum

+∞

7.3

WB402

NOMESCO Finland

Demanding antibody therapy of primary tumour

+∞

7.3

C25.2

ICD-10 Finland

Malignant neoplasm: Tail of pancreas

+∞

7.3

C50.29

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology

+∞

7.3

C50.50

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, no histological veryfication

+∞

7.3

L02BA03

ATC

fulvestrant; parenteral

+∞

7.3

192

Kela drug reimbursment

Fulvestrant

+∞

7.3

C85.1

ICD-10 Finland

B-cell lymphoma, unspecified

+∞

7.3

3012

Kela drug reimbursment

Cabozantinib

+∞

7.3

8070/3-C44.3

ICD-O-3

Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

7.3

WW300

NOMESCO Finland

Transfer of autologic stem cells

+∞

7.3

8140/3-C34.1

ICD-O-3

Adenocarcinoma, NOS, of upper lobe, lung

+∞

7.3

L01XE01

ATC

[U] imatinib; oral

+∞

7.3

C34.30

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung without histology

+∞

7.3

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

+∞

7.3

C56.98

ICD-10 Finland

Malignant tumor of the ovary, indeterminate histology

+∞

7.3

C50.9

ICD-10 Finland

Malignant neoplasm: Breast, unspecified

+∞

7.3

1502

Kela drug reimbursment

Cabozantinib

+∞

7.3

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

+∞

7.3

TQW40

NOMESCO Finland

Remowal of suture of skin

1.5

7.3

223

1490

M01AB55

ATC

diclofenac, combinations; oral

1.5

7.3

235

1590

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.6

7.3

183

1167

M54.3

ICD-10 Finland

Sciatica

1.5

7.3

214

1418

R09

ICPC

Sinus symptom/complaint

1.5

7.2

259

1789

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.7

7.2

141

837

SPAT1229

SPAT

Assessment of need for aid

1.5

7.2

243

1657

9702

FHL

Breast exploration and possible tumor removal

2.7

7.2

177

SDA04

NOMESCO Finland

Very demanding parodonthologic therapy

1.2

7.2

886

7398

9736

FHL

Subcutaneous tumor removal in operating room or anesthesia

2.5

7.2

202

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

1.8

7.2

121

689

XX2AT

NOMESCO Finland

Other injection with ultrasound examination

4.1

7.2

D22.7

ICD-10 Finland

Melanocytic naevi of lower limb, including hip

2.5

7.2

221

NER20

NOMESCO Finland

Incomplete excision of soft tissue tumour of pelvis

30.0

7.1

SPAT1216

SPAT

Assessment of functional ability

1.3

7.1

495

3839

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

1.4

7.1

304

2174

JGB03

NOMESCO Finland

Partial proctectomy with partial excision of mesorectum

20.0

7.1

H02AB04

ATC

methylprednisolone; systemic

1.3

7.1

516

4028

D21.9

ICD-10 Finland

Benign neoplasm: Connective and other soft tissue, unspecified

5.0

7.1

PJA10

NOMESCO Finland

Exploration of lymph nodes

4.2

7.1

JG1BG

NOMESCO Finland

MRI of rectum

12.0

7.1

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

1.5

7.1

244

1675

G04CB02

ATC

dutasteride; oral

1.6

7.1

171

1079

D37.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Rectum

5.3

7.1

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.2

7.0

933

7852

D44.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Thyroid gland

2.9

7.0

144

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.3

7.0

532

4179

R03BA01

ATC

beclometasone; inhalant

1.3

7.0

508

3965

L13

ICPC

Hip symptom/complaint

1.3

7.0

557

4407

R60.9

ICD-10 Finland

Oedema, unspecified

1.7

7.0

146

889

BA1AE

NOMESCO Finland

Thyroiid ultrasound examination

2.4

6.9

238

E0000UV

ATC

1.2

6.9

1428

12554

D23.3

ICD-10 Finland

Benign neoplasm: Skin of other and unspecified parts of face

2.2

6.9

322

QBE40

NOMESCO Finland

Repair of anomaly or lesion after disease of skin of trunk

13.8

6.9

JN5ER

NOMESCO Finland

PET-CT of receptors in whole body

13.8

6.9

K08.80

ICD-10 Finland

Toothache NOS

1.4

6.9

281

1994

J20

ICD-10 Finland

Acute bronchitis

1.4

6.8

315

2287

M54

ICD-10 Finland

Dorsalgia

1.4

6.8

384

2885

R13

ICD-10 Finland

Dysphagia

1.5

6.8

210

1405

M01AH02

ATC

rofecoxib; oral

1.3

6.8

472

3661

K40.9

ICD-10 Finland

Unilateral or unspecified inguinal hernia, without obstruction or gangrene

1.4

6.8

380

2853

D25.1

ICD-10 Finland

Intramural leiomyoma of uterus

1.5

6.8

189

1238

H03AA01

ATC

levothyroxine sodium; systemic

1.2

6.8

841

7026

M01AC01

ATC

piroxicam; systemic, rectal

1.3

6.8

485

3781

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.5

6.8

202

1345

SPAT1097

SPAT

Recording of ECG

1.3

6.8

522

4111

BA3AT

NOMESCO Finland

Cytology of thyroid with ultrasound quidance

2.5

6.8

198

9707

FHL

Ablation of mammae and removal of axillary lymph nodes

40.1

6.8

PJD44

NOMESCO Finland

Excision of iliac lymph nodes

40.1

6.8

D17.4

ICD-10 Finland

Benign lipomatous neoplasm of intrathoracic organs

40.1

6.8

NBR30

NOMESCO Finland

Extensive or radical excision of soft tissue tumour of shoulder or upper arm

40.1

6.8

C43.60

ICD-10 Finland

Malignant melanoma of the upper extremity including the shoulder without histology

40.1

6.8

EJA10

NOMESCO Finland

Biopsy of tongue or floor of mouth

2.2

6.8

308

QBE20

NOMESCO Finland

Excision and repair of scar or web of skin of trunk

3.8

6.7

ZXA10

NOMESCO Finland

Bilateral

1.3

6.7

629

5085

YA1VG

NOMESCO Finland

MRI examination of head and neck with high intesity magnet for dose design of radiotherapy

22.5

6.7

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

1.4

6.7

354

2634

M79.1

ICD-10 Finland

Myalgia

1.3

6.7

448

3463

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.3

6.6

581

4656

M77.4

ICD-10 Finland

Metatarsalgia

1.5

6.6

187

1230

G04BE01

ATC

alprostadil; parenteral, urethral

2.9

6.6

123

B01AB04

ATC

dalteparin; parenteral

1.7

6.6

132

794

R86.0

ICD-10 Finland

Abnormal findings in specimens from male genital organs, abnormal level of enzymes

2.9

6.6

132

VALMI

NOMESCO Finland

1.2

6.6

901

7606

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.4

6.6

384

2901

D30.0

ICD-10 Finland

Benign neoplasm: Kidney

3.5

6.6

D25.9

ICD-10 Finland

Leiomyoma of uterus, unspecified

1.4

6.5

285

2047

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

2.9

6.5

124

WX400

NOMESCO Finland

Inhalation anesthesy

1.7

6.5

131

787

T90

ICPC

Diabetes non-insulin dependent

1.2

6.5

816

6821

J30.3

ICD-10 Finland

Other allergic rhinitis

1.7

6.5

117

683

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.4

6.5

330

2438

A98

ICPC

Health maint/preventive medicine

1.3

6.5

4471

43656

TQB05

NOMESCO Finland

Puncture of skin of trunk

4.5

6.4

M96.1

ICD-10 Finland

Postlaminectomy syndrome, not elsewhere classified

3.3

6.4

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

1.6

6.4

169

1091

NFR30

NOMESCO Finland

Extended excision of soft tissue tumour of hip or thigh

69.9

6.4

189

Kela drug reimbursment

Imatinib

69.9

6.4

C73.92

ICD-10 Finland

Follicular carcinoma of the thyroid gland

69.9

6.4

QX1CG

NOMESCO Finland

Extensive magnetic study of superficial resistance

69.9

6.4

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

1.5

6.4

243

1700

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.4

6.4

289

2093

A05

ICPC

Feeling ill

1.6

6.4

166

1070

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

0.6

6.4

129

1979

H04.10

ICD-10 Finland

Dry eye syndrome

1.4

6.4

341

2541

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

4.2

6.4

QBE30

NOMESCO Finland

Excision and repair of surgical scar in trunk

4.7

6.4

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.4

6.4

291

2111

E66.01

ICD-10 Finland

Obesity due to excess calories

1.4

6.4

273

1959

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.3

6.4

405

3105

J45.8

ICD-10 Finland

Mixed asthma

1.8

6.3

102

576

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.3

6.3

365

2760

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

18.0

6.3

HAC15

NOMESCO Finland

Subcutaneous mastectomy with excision of mamilla

18.0

6.3

8720/3-C44.7

ICD-O-3

Malignant melanoma, NOS, of skin of lower limb and hip

+∞

6.2

1742A

ICD-9 Finland

Malignant neoplasm of female breast, Upper-inner quadrant

+∞

6.2

8260/3-C64.9

ICD-O-3

Papillary adenocarcinoma, NOS, of kidney, NOS

+∞

6.2

C50.22

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,lobular tumor

+∞

6.2

L01AX03

ATC

temozolomide; systemic

+∞

6.2

8140/3-C18.9

ICD-O-3

Adenocarcinoma, NOS, of colon, NOS

+∞

6.2

YA1CD

NOMESCO Finland

Very extensive CT examination of head and neck for dose design of radiotherapy

+∞

6.2

352

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

6.2

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

+∞

6.2

C21.0

ICD-10 Finland

Malignant neoplasm: Anus, unspecified

+∞

6.2

YNB10

NOMESCO Finland

Collection of stem cells for transplant

+∞

6.2

8500/3-C50.1

ICD-O-3

Infiltrating duct carcinoma, NOS, of central portion of breast

+∞

6.2

C49.12

ICD-10 Finland

Malignant tumor of connective tissue and soft tissue of upper extremity including shoulder liposarcoma

+∞

6.2

C18.09

ICD-10 Finland

Malignant tumor of caecum other or unspecified histology

+∞

6.2

C18.79

ICD-10 Finland

Malignant tumor of the sigmoid or other unspecified histology

+∞

6.2

C43.70

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip without histology

+∞

6.2

C50.32

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, lobular tumor

+∞

6.2

C49.19

ICD-10 Finland

Malignant tumor of connective tissue and soft tissue of upper extremity including shoulder other or unspecified tumor

+∞

6.2

C73.99

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland), other or unspecified histology

+∞

6.2

C18

ICD-10 Finland

Malignant neoplasm of colon

+∞

6.2

8317/3-C64.9

ICD-O-3

Renal cell carcinoma, chromophobe type of kidney, NOS

+∞

6.2

8140/3-C18.4

ICD-O-3

Adenocarcinoma, NOS, of transverse colon

+∞

6.2

8500/3-C50.3

ICD-O-3

Infiltrating duct carcinoma, NOS, of lower-inner quadrant of breast

+∞

6.2

C25.1

ICD-10 Finland

Malignant neoplasm: Body of pancreas

+∞

6.2

C56.00

ICD-10 Finland

Malignant tumor of the ovary without histology

+∞

6.2

C16.9

ICD-10 Finland

Malignant neoplasm: Stomach, unspecified

+∞

6.2

191

Kela drug reimbursment

Erlotinib

+∞

6.2

C18.41

ICD-10 Finland

Malignant tumor of the transverse colon invasive carcinoma

+∞

6.2

K03.00

ICD-10 Finland

Approximal wear

1.5

6.2

181

1198

KBJ10

NOMESCO Finland

Cutaneous ureteroenterostomy

26.7

6.2

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

2.2

6.2

271

F45.8

ICD-10 Finland

Other somatoform disorders

1.5

6.2

222

1539

H01

ICPC

Ear pain/earache

1.4

6.2

348

2617

SPAT1058

SPAT

PEF monitoring instruction

1.4

6.2

284

2063

U07

ICPC

Urine symptom/complaint other

1.5

6.2

177

1170

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.3

6.1

386

2951

SPAT1360

SPAT

Extensive global examination

1.4

6.1

245

1735

R06.5

ICD-10 Finland

Mouth breathing

1.4

6.1

309

2280

J45

ICD-10 Finland

Asthma

1.4

6.1

338

2533

D07AC01

ATC

betamethasone; topical

1.2

6.1

1267

11124

R35

ICD-10 Finland

Polyuria

1.5

6.1

190

1277

XX3AT

NOMESCO Finland

Other labeling with ultrasound guidance

7.7

6.1

M79.7

ICD-10 Finland

Fibromyalgia

1.7

6.1

120

717

N01

ICPC

Headache

1.4

6.1

306

2257

SPAT1043

SPAT

Audiometry

1.4

6.1

327

2441

J02AC02

ATC

itraconazole; systemic

1.3

6.1

656

5392

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.4

6.1

341

2565

L60.0

ICD-10 Finland

Ingrowing nail

1.6

6.1

135

839

EP1CM

NOMESCO Finland

Extensive MRI examination of soft tissue of neck with 3 Tesla magnet

8.6

6.0

J34.2

ICD-10 Finland

Deviated nasal septum

1.5

6.0

183

1224

N06AX16

ATC

venlafaxine; oral

1.3

6.0

461

3629

D17.5

ICD-10 Finland

Benign lipomatous neoplasm of intra-abdominal organs

10.0

6.0

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.0

6.0

366

104

Kela drug reimbursment

Thyroid insufficiency

1.4

6.0

232

1632

C03BA11

ATC

indapamide; oral

1.8

6.0

100

572

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3002256) Pathology report gross observation

1422

3643

4.92

307.65

1.3

1.1

—

(40768804) Tissue Pathology biopsy report

2575

15333

2.28

188.79

2.3

1.7

—

(4035726)

442

1380

3.40

114.63

1.4

1.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

517

2114

2.60

81.70

3.6

1.6

12.2

10.0

ug/l

0.13

409

1545

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2535

18431

1.70

77.39

4.1

3.6

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2708

20446

1.64

68.37

5.8

3.8

11.0

11.4

umol/l

0.69

2587

19153

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3951

32948

1.72

66.86

7.6

5.5

77.7

75.1

u/l

2.12

3743

30670

(3044640) Blood type and Crossmatch panel - Blood

1707

11802

1.65

58.73

2.3

2.1

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

2957

23648

1.55

52.55

8.2

6.8

4.0

4.2

e9/l

4.67

2576

20425

(3024561) Albumin [Mass/volume] in Serum or Plasma

2256

17057

1.55

51.35

4.7

3.9

35.9

36.1

g/l

1.09

2086

15681

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2578

20326

1.51

46.73

6.8

5.6

1.2

mmol/l

2.58

2234

17155

(40768793) Breast Pathology biopsy report

124

312

4.04

43.94

1.2

—

(3031040) Bacteria [#/volume] in Urine by Automated count

3330

27941

1.49

42.73

4.7

4.1

1713.6

1653.4

e6/l

0.02

360

(3013826) Glucose [Moles/volume] in Serum or Plasma

3018

24955

1.47

40.79

4.7

4.2

6.7

mmol/l

0.65

2853

23169

(3015377) Calcium [Moles/volume] in Serum or Plasma

1743

12973

1.50

39.95

3.2

2.0

2.3

2.4

mmol/l

1.13

1500

11008

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1786

13403

1.49

39.13

2.5

2.3

56.2

58.1

u/l

0.46

1654

12346

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2301

18244

1.45

37.61

5.8

5.2

1.2

mmol/l

1.39

2099

16273

(3037467) Urinalysis macro (dipstick) panel - Urine

3504

30113

1.46

36.71

4.6

4.0

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1273

9001

1.54

36.55

2.2

2.0

—

(3013707) Erythrocyte sedimentation rate by Westergren method

3848

33747

1.47

35.67

4.3

4.1

11.0

11.2

mm/h

0.43

3622

31386

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

4887

45266

1.75

35.06

14.9

11.6

21.8

21.7

mg/l

0.11

3977

34829

(3013115) Eosinophils [#/volume] in Blood

2716

22428

1.42

34.36

5.7

5.8

0.2

e9/l

0.69

2407

19724

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

9.00

34.19

6.1

1.3

—

(40768800) Prostate Pathology biopsy report

217

4.20

33.82

1.2

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

4625

42362

1.60

33.11

5.3

4.7

1.8

2.1

mu/l

2.12

4308

39081

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

20.92

32.93

1.2

1.1

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

5014

46924

1.83

32.90

16.8

13.5

139.9

139.8

mmol/l

1.95

4923

45723

(3023103) Potassium [Moles/volume] in Serum or Plasma

5028

47099

1.85

32.83

17.0

13.6

4.0

mmol/l

0.79

4926

45810

(3002030) Lymphocytes/100 leukocytes in Blood

2518

20646

1.41

32.46

5.9

28.6

0.00

2340

19111

(40768795) Lymph node Pathology biopsy report

103

5.78

32.34

1.2

1.1

—

(3019198) Lymphocytes [#/volume] in Blood

2676

22181

1.40

32.34

5.5

5.7

1.9

e9/l

0.61

2383

19535

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

7.68

32.26

1.4

1.1

—

(3001604) Monocytes [#/volume] in Blood

2609

21557

1.40

31.98

5.5

5.6

0.6

e9/l

0.97

2273

18634

(3006315) Basophils [#/volume] in Blood

2620

21668

1.40

31.92

5.5

5.6

0.0

e9/l

0.22

2285

18727

(3018010) Neutrophils/100 leukocytes in Blood

2492

20456

1.40

31.60

5.7

56.6

56.8

0.47

2323

19027

(3019069) Monocytes/100 leukocytes in Blood

2453

20087

1.40

31.53

6.1

8.5

0.76

2299

18705

(3006504) Eosinophils/100 leukocytes in Blood

2440

19981

1.40

31.26

5.8

2.9

3.0

0.94

2279

18500

(3022096) Basophils/100 leukocytes in Blood

2369

19355

1.40

30.51

5.8

5.9

0.7

0.22

2207

17925

(42870588) Differential panel, method unspecified - Blood

1807

14120

1.42

30.02

5.6

5.7

—

(3032080) INR in Blood by Coagulation assay

2043

16354

1.40

29.34

8.2

8.9

1.2

1.3

inr

2.58

518

4791

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

159

610

2.65

28.31

1.4

1.2

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

3964

35521

1.42

28.28

4.4

3.9

14.8

14.7

pmol/l

0.79

3651

32549

(3023368) Bacteria identified in Blood by Culture

1327

9906

1.45

27.96

4.0

3.8

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

185

780

2.42

27.05

3.0

2.1

4487.0

102.5

u/ml

0.53

144

642

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3475

30601

1.37

26.40

3.3

2.9

47.3

44.5

u/l

0.97

3270

28569

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

5144

48935

1.87

26.16

11.1

8.8

27.0

26.6

u/l

0.83

4995

47139

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1297

9790

1.43

25.33

1.7

1.0

mg/l

0.03

1000

7402

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

576

3690

1.63

24.47

4.3

2.9

247.7

234.1

u/l

1.09

536

3438

(40761511) CBC panel - Blood by Automated count

5013

47623

1.64

21.87

14.1

11.2

—

(3024731) MCV [Entitic volume]

5291

51076

2.13

21.81

21.9

17.1

90.6

91.0

8.19

5237

50353

(3035941) MCH [Entitic mass]

5291

51077

2.13

21.79

21.9

17.1

30.2

30.3

9.66

5237

50355

(3010813) Leukocytes [#/volume] in Blood

5292

51094

2.14

21.72

22.1

17.2

6.6

e9/l

0.40

5173

49616

(3026361) Erythrocytes [#/volume] in Blood

5291

51085

2.13

21.65

22.0

17.2

4.6

4.5

e12/l

1.26

5175

49616

(3007461) Platelets [#/volume] in Blood

5288

51046

2.12

21.64

22.0

17.2

255.0

252.6

e9/l

1.94

5192

49731

(3000963) Hemoglobin [Mass/volume] in Blood

5291

51095

2.12

21.47

22.1

17.3

136.8

137.2

g/l

1.04

5238

50367

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1744

14194

1.34

20.55

3.4

2.7

31.1

33.7

u/l

1.05

1662

13424

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2187

18384

1.32

20.52

2.3

2.2

77.9

77.5

nmol/l

0.26

1952

16528

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

117

465

2.55

19.50

3.0

2.2

1082.5

73.3

u/ml

0.88

104

424

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2220

18800

1.30

19.37

2.9

2.8

124.1

115.1

ug/l

0.70

2075

17472

(3018418) pH of Serum or Plasma

1478

11834

1.34

19.18

3.9

3.3

7.4

0.96

240

2104

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

183

3.53

19.06

4.9

1.2

214.8

140.6

u/ml

0.21

(3033658) Prothrombin time (PT) actual/Normal

1287

10121

1.36

18.74

3.8

3.5

93.8

90.8

4.12

1260

9842

(3026493) Urate [Moles/volume] in Serum or Plasma

1476

11850

1.34

18.72

2.8

2.3

2584.3

4413.3

umol/l

1.52

1280

10284

(3044889) 12 lead EKG panel

3532

31876

1.31

18.71

3.9

3.6

—

(3042936) Bacteria identified in Isolate by Culture

763

5496

1.45

18.60

2.0

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

292

1684

1.78

18.26

2.3

1.5

29.2

27.1

u/ml

0.19

283

1603

(3003396) Base excess in Arterial blood by calculation

611

4232

1.50

18.15

6.4

7.3

1.0

1.2

mmol/l

0.69

488

3233

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

4587

43088

1.40

18.03

6.2

5.7

39.6

39.7

mmol/mol

0.17

4283

40209

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

3228

28876

1.29

17.82

3.0

2.9

—

(3002582) Erythrocytes [#/volume] in Urine

1493

12084

1.32

17.72

3.3

2.9

71.2

90.8

e6/l

0.27

1149

9098

(3026008) Bacteria identified in Urine by Culture

1483

12006

1.32

17.53

3.4

2.9

—

(3018095) Leukocytes [#/volume] in Urine

1744

14441

1.31

17.50

3.8

3.4

71.7

93.8

e6/l

0.90

1249

9937

(3027801) Oxygen [Partial pressure] in Arterial blood

608

4252

1.48

17.19

6.4

7.3

12.1

11.9

kpa

0.36

573

4044

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

608

4254

1.48

17.14

6.4

7.3

5.0

5.1

kpa

0.42

576

4051

(40768797) Stomach Pathology biopsy report

832

6179

1.41

17.03

1.2

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

4962

47409

1.51

16.71

5.3

5.0

2.8

mmol/l

0.05

4637

44133

(3009261) Glucose [Presence] in Urine by Test strip

2523

22008

1.27

16.50

3.7

3.5

0.0

estimate

1.96

436

3683

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

4894

46649

1.47

16.48

4.8

4.5

4.7

mmol/l

0.16

4598

43649

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1079

8432

1.35

16.03

3.9

3.6

166.0

466.7

ng/l

5.05

773

6365

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

4762

45202

1.42

16.02

5.0

4.5

6.0

5.9

mmol/l

0.78

4414

41607

(3035350) Ketones [Presence] in Urine by Test strip

2486

21697

1.27

16.00

3.7

3.5

0.0

estimate

0.80

427

3735

(3021601) Nitrite [Presence] in Urine by Test strip

2492

21779

1.27

15.77

5.1

4.6

0.0

estimate

0.80

447

3813

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1962

16673

1.28

15.63

3.5

3.4

33.4

56.9

ng/l

2.46

1277

10848

(3049717) Cytology report of Urine Cyto stain

212

1167

1.85

15.48

2.4

1.8

—

(3030467) Casts [#/volume] in Urine by Automated count

1368

11123

1.31

15.30

3.2

2.9

0.4

e6/l

0.02

1033

8217

(3012095) Magnesium [Moles/volume] in Serum or Plasma

794

5951

1.39

15.28

3.2

2.6

0.8

mmol/l

1.10

735

5493

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1330

10780

1.31

15.21

4.7

3.4

22.1

23.8

3.76

674

4739

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

181

3.23

15.14

2.1

1.3

21.8

17.7

ug/l

0.32

176

(3022145) Colonoscopy Study observation

637

4611

1.43

14.95

1.4

1.3

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

309

1916

1.65

14.84

7.7

10.5

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

912

7029

1.36

14.71

2.7

2.1

2.4

mmol/l

0.09

791

6011

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

391

2577

1.56

14.57

1.5

1.6

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1608

13430

1.28

14.47

5.2

3.5

3.2

2.1

ug/l

0.93

1468

12157

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

4853

46366

1.42

14.36

4.7

4.4

1.4

1.5

mmol/l

4.48

4542

43166

(3007853) Bacteria identified in Skin by Aerobe culture

659

4834

1.41

14.33

1.8

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

396

2635

1.54

14.13

3.1

4.5

pmol/l

0.43

352

2338

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

4549

43040

1.34

14.09

13.5

10.5

81.9

81.7

ml/min/173m2

0.27

3832

34884

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

617

4498

1.42

13.88

2.7

2.2

6.7

7.1

umol/l

0.21

525

3854

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

983

7734

1.33

13.72

1.6

1.5

—

(3016502) Oxygen saturation in Arterial blood

534

3802

1.45

13.66

6.8

7.8

95.9

95.4

1.51

511

3650

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1256

10270

1.29

13.14

2.2

2.3

2.9

mg/l

0.04

1086

8781

(3013512) EKG study

1498

12530

1.27

13.04

4.3

3.7

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

492

3483

1.45

12.96

7.3

8.2

124.6

123.4

g/l

0.68

473

3346

(3017446) Testosterone [Moles/volume] in Serum or Plasma

416

2850

1.50

12.94

2.4

2.2

12.4

14.1

nmol/l

3.79

371

2537

(3022217) INR in Platelet poor plasma by Coagulation assay

721

5457

1.37

12.94

24.4

24.7

1.3

inr

0.19

124

803

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2096

18239

1.24

12.88

2.0

1.9

98.6

96.7

pmol/l

0.82

1078

9294

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

185

2.99

12.71

1.5

4.8

3.9

mg/l

0.54

178

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

4700

44830

1.35

12.65

4.2

4.0

1.3

mmol/l

2.64

4386

41431

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

800

6174

1.35

12.64

3.0

2.6

2.7

e6/l

0.11

430

3235

(3019225) pH of Specimen

558

4063

1.42

12.60

4.4

3.6

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1227

10052

1.28

12.57

1.3

2.0

1.9

u/ml

0.07

336

2821

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

871

6832

1.33

12.30

2.7

2.5

1.1

e6/l

0.23

502

3877

(3015736) pH of Urine

1943

16829

1.24

12.30

3.5

3.3

—

5.7

—

(36304419) Bacteria [Presence] in Urine

1312

10867

1.27

12.26

3.0

2.8

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

441

3092

1.46

12.21

2.4

2.1

0.2

g/l

0.60

420

2817

(3047181) Lactate [Moles/volume] in Blood

207

1217

1.73

12.18

5.1

6.1

1.2

1.3

mmol/l

0.63

187

1064

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1428

11988

1.26

11.85

3.0

1071.0

1266.5

ng/l

1.38

1226

10203

(40758558) Short blood count panel - Blood

1209

9965

1.27

11.68

5.9

5.0

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

785

6120

1.33

11.52

1.8

1.7

—

(3000850) Epithelial cells [#/volume] in Urine

1037

8409

1.29

11.38

2.7

2.4

5.2

5.5

e6/l

0.31

907

7279

(3019060) Gas panel - Arterial blood

371

2555

1.48

11.25

4.4

5.0

—

(3048689) Calprotectin [Mass/mass] in Stool

711

5483

1.34

11.22

2.3

128.2

131.1

ug/g

0.08

568

4333

(3030981) Hyaline casts [#/volume] in Urine by Automated count

304

2012

1.54

11.14

2.8

2.4

0.3

e6/l

0.02

294

1947

(3013139) Helicobacter pylori Ag [Presence] in Stool

442

3164

1.43

10.96

1.2

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

946

7621

1.29

10.87

3.1

2.5

0.8

0.7

ug/l

1.31

628

4767

(3026782) Osmolality of Urine

945

7638

1.29

10.56

2.9

2.6

554.1

545.1

mosm/kgh2o

0.52

818

6396

(3039000) Anion gap in Blood

149

835

1.81

10.39

5.9

7.3

11.0

11.4

mmol/l

0.69

133

744

(3036481) Cortisol [Moles/volume] in Serum or Plasma

517

3840

1.38

10.35

2.2

1.8

375.9

365.0

nmol/l

0.70

478

3501

(3018572) Chloride [Moles/volume] in Blood

149

836

1.80

10.35

5.9

7.3

105.2

105.1

mmol/l

0.07

133

745

(3022948) Iron [Moles/volume] in Serum or Plasma

798

6329

1.31

10.28

2.3

2.5

13.4

13.6

umol/l

0.34

737

5851

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

485

3574

1.39

10.18

2.9

132.8

176.3

ng/l

2.90

436

3260

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

248

1604

1.57

10.09

4.9

5.0

1.7

0.05

230

1500

(3003458) Phosphate [Moles/volume] in Serum or Plasma

645

4998

1.33

9.80

5.4

5.6

1.0

mmol/l

0.28

590

4621

(3021960) Folate [Moles/volume] in Serum or Plasma

1175

9829

1.25

9.78

1.5

20.1

20.7

nmol/l

0.74

1004

8383

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

475

3525

1.38

9.56

2.3

2.2

71.1

67.4

ml/min/173m2

1.22

185

1296

(3007930) Methemoglobin/Hemoglobin.total in Blood

243

1585

1.56

9.54

5.0

5.1

0.9

1.00

224

1487

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

332

2312

1.46

9.54

2.5

2.4

—

(3000492) Spirometry study

584

4485

1.34

9.43

1.4

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1919

16955

1.20

9.24

3.9

3.6

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

451

2.03

9.21

1.5

1.4

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

980

8093

1.26

9.06

1.3

9.5

12.4

u/ml

0.28

355

3236

(3035637) Corticotropin [Mass/volume] in Plasma

397

2.08

8.86

1.4

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

672

5315

1.30

8.78

2.3

2.7

22.5

23.5

0.92

563

4521

(3004789) Transferrin [Mass/volume] in Serum or Plasma

724

5787

1.29

8.72

2.2

2.6

2.4

g/l

1.03

665

5359

(3008152) Bicarbonate [Moles/volume] in Arterial blood

344

2455

1.43

8.69

6.5

7.1

24.6

mmol/l

0.19

321

2267

(4010399)

448

3350

1.37

8.60

1.5

1.4

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

6.38

8.52

2.5

1.0

1.2

1.3

ug/l

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

271

1856

1.48

8.50

8.1

9.7

24.4

mmol/l

0.12

250

1709

(4281824)

242

2.37

8.47

1.1

1.2

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

602

4715

1.31

8.45

6.2

6.7

104.5

104.3

mmol/l

0.32

589

4610

(3017732) Neutrophils [#/volume] in Blood

422

3139

1.37

8.38

3.1

2.7

4.1

e9/l

0.23

325

2434

(3007164) IgA [Mass/volume] in Serum or Plasma

1023

8561

1.24

8.34

1.6

1.3

2.3

2.5

g/l

1.55

638

5169

(3003694) ABO and Rh group [Type] in Blood

1275

10920

1.22

8.31

1.4

—

(3025941) Bacteria identified in Stool by Culture

338

2427

1.42

8.27

1.3

1.2

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1580

13836

1.20

8.14

2.2

2.1

153.8

231.4

u/l

5.02

1483

12958

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1015

8508

1.24

8.13

1.3

20.9

35.3

iu/ml

4.15

310

2664

(3009542) Hematocrit [Volume Fraction] of Blood

4369

41794

1.23

8.12

15.7

12.7

40.4

40.2

0.94

3112

30479

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

364

2.08

8.09

2.2

2.1

1723.0

356.6

u/ml

0.36

349

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

232

1558

1.51

8.02

2.1

1.8

—

(3000494) Fungus identified in Specimen by Culture

646

5160

1.29

7.80

1.5

1.4

—

(3012516) Albumin [Mass/volume] in Urine

1561

13714

1.19

7.67

3.4

3.2

444.3

333.8

mg/l

0.38

991

8547

(3037756) Immunofixation for Serum or Plasma

117

671

1.76

7.66

1.8

1.2

—

(3009343) pH of Capillary blood

341

2491

1.39

7.57

3.6

3.3

7.4

0.12

308

(3020682) Albumin/Creatinine [Ratio] in Urine

1635

14441

1.19

7.54

4.0

6.6

8.2

mg/mmol

1.07

1050

9064

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

345

2528

1.39

7.52

3.7

3.3

5.1

5.2

kpa

0.82

313

2327

(3009214) Lutropin [Units/volume] in Serum or Plasma

162

1027

1.60

7.28

1.4

1.3

12.1

9.8

u/l

1.18

137

846

(3041096) Erythrocytes [Presence] in Urine by Automated

1345

11723

1.20

7.14

3.4

3.1

—

(40760892) CBC W Ordered Manual Differential panel - Blood

1136

9753

1.21

7.09

4.4

4.2

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

327

2401

1.38

7.06

3.6

3.2

2.0

1.7

mmol/l

0.52

238

1769

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

690

5623

1.26

7.05

4.8

4.6

32.6

32.2

0.33

491

3875

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

478

3722

1.31

7.00

2.4

2.2

31.3

51.3

u/l

0.90

403

3165

(3003338) MCHC [Mass/volume]

4126

39410

1.19

6.99

18.6

15.0

332.6

332.7

g/l

0.58

4104

39156

(3009508) Creatinine [Moles/volume] in Urine

1635

14536

1.18

6.84

3.3

3.2

7.8

7.6

mmol/l

0.74

1400

12291

(3000570) Elastase.pancreatic [Mass/mass] in Stool

180

1191

1.53

6.73

1.4

293.5

298.5

ug/g

0.11

100

681

(3037121) Protein [Mass/volume] in Urine

191

1281

1.51

6.71

3.1

2.6

0.2

0.3

g/l

1.64

448

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

178

1183

1.52

6.53

2.5

3.0

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

209

1437

1.47

6.51

2.0

1.7

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

302

2220

1.38

6.49

1.5

1.4

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

740

6148

1.24

6.35

2.0

29.6

29.8

0.28

716

5946

(3002385) Erythrocyte distribution width [Ratio]

3939

37580

1.17

6.32

17.6

13.9

13.7

13.6

2.53

3877

36706

(3019150) Specific gravity of Urine by Refractometry

1118

9703

1.19

6.11

4.1

3.9

1.0

kg/l

0.57

165

1393

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

180

1227

1.48

5.89

1.1

12.3

7.5

u/ml

0.38

151

(3000991) Gas panel - Venous blood

390

3029

1.31

5.84

7.5

8.5

—

(3017181) Myelocytes/100 leukocytes in Blood

430

3385

1.29

5.82

4.2

3.9

0.9

0.6

1.29

119

692

(3005719) IgG [Mass/volume] in Serum or Plasma

396

3087

1.30

5.78

2.4

2.3

10.3

10.8

g/l

1.55

355

2824

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

303

2280

1.35

5.66

8.2

9.4

0.7

0.08

303

2261

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

2.83

5.66

4.0

2.4

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1101

9606

1.18

5.62

1.7

78493876.8

34694309.2

pmol/l

0.95

916

8036

(3022313) Gas panel - Capillary blood

250

1827

1.39

5.61

3.9

3.3

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

305

2302

1.34

5.59

1.0

1.1

—

(40765096) Chromosome analysis panel by Banding

3.47

5.44

1.2

1.1

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1418

12655

1.16

5.43

1.8

1.6

1.4

mmol/l

0.78

1211

10615

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

194

1367

1.43

5.38

2.1

1.8

3.0

1.5

ug/l

0.54

173

1196

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

520

4241

1.25

5.28

1.6

1.7

—

(3045142) Bone marrow Pathology biopsy report

269

1.98

5.20

1.2

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

594

1.64

5.13

1.4

1.3

33.4

29.5

u/l

0.53

450

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

516

4220

1.25

5.11

1.6

1.7

—

(3023520) Reticulocytes [#/volume] in Blood

392

3104

1.28

5.10

2.6

2.3

69.1

70.3

e9/l

0.29

315

2335

(3027945) Reticulocytes/100 erythrocytes in Blood

512

4190

1.24

5.05

2.4

2.2

1.7

1.8

0.18

457

3668

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

179

1259

1.44

5.04

1.4

—

(3014007) Fractional oxyhemoglobin in Arterial blood

300

2296

1.32

5.03

8.3

9.4

94.5

93.5

4.59

300

2286

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

397

3155

1.28

5.02

3.5

3.7

82.0

90.4

ng/l

1.40

338

2702

(3002179) Metamyelocytes/100 leukocytes in Blood

395

3138

1.28

5.01

3.8

0.6

0.5

0.35

529

(3002032) Base excess in Venous blood by calculation

444

3581

1.26

4.97

4.3

3.7

1.9

2.0

mmol/l

0.20

378

2929

(3027273) Bicarbonate [Moles/volume] in Venous blood

255

1909

1.35

4.97

4.4

3.2

25.2

mmol/l

0.03

250

1836

(3023323) Follitropin [Units/volume] in Serum or Plasma

263

1982

1.34

4.91

1.3

30.2

31.4

iu/l

0.22

229

1736

(3003327) Ova and parasites identified in Stool by Light microscopy

202

1460

1.40

4.89

1.6

1.8

—

(3004809) Band form neutrophils/100 leukocytes in Blood

466

1.71

4.83

3.0

1.8

1.2

0.88

353

(3021589) Normoblasts [#/volume] in Blood

2078

19169

1.14

4.83

9.2

8.2

0.0

e9/l

0.47

1694

15688

(40761535) Cells panel - Urine sediment

443

3593

1.25

4.74

3.5

3.4

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

495

4065

1.24

4.74

1.4

1.3

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1165

10341

1.16

4.72

3.6

3.5

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

537

4453

1.23

4.69

1.6

—

(36660697) Celiac disease serology panel - Serum

447

3634

1.25

4.69

1.2

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

330

1.83

4.67

2.6

2.8

—

(3035320) C reactive protein [Mass/volume] in Body fluid

302

1.86

4.64

2.2

2.5

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

198

2.08

4.64

1.7

1.9

—

(3028026) IgM [Mass/volume] in Serum or Plasma

311

2427

1.30

4.56

1.9

1.5

1.2

g/l

0.01

278

2227

(3021440) Promyelocytes/100 leukocytes in Blood

405

3267

1.26

4.55

4.2

4.0

0.1

0.45

111

641

(3021447) Carbon dioxide [Partial pressure] in Venous blood

441

3594

1.25

4.53

4.2

3.7

5.8

5.9

kpa

0.53

431

3488

(21494434) Karyotype in Bone marrow

263

1.91

4.48

1.1

1.2

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

406

3284

1.26

4.46

6.6

7.0

1.3

1.4

mmol/l

1.03

400

3162

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

531

1.63

4.46

1.0

1.1

—

(4094501)

189

1374

1.39

4.45

1.1

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

662

5638

1.20

4.41

7.1

6.2

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

156

1102

1.43

4.34

2.8

3.4

0.4

0.3

u/ml

0.33

644

(40768441) Liver Pathology biopsy report

224

1.97

4.34

1.5

1.4

—

(40768443) Skin Pathology biopsy report

236

1786

1.34

4.32

1.2

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

214

1603

1.35

4.21

4.4

3.4

25.0

24.8

mmol/l

0.19

200

1474

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

166

1196

1.40

4.15

1.2

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

207

1553

1.35

4.04

2.5

1.4

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

376

1.71

4.04

1.1

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

207

1554

1.35

4.03

2.5

1.4

7.4

g/l

0.05

147

1154

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

817

7139

1.17

4.02

1.5

1.4

—

(3037522) Nuclear Ab [Titer] in Serum

756

6565

1.18

4.02

1.4

1.3

461.2

542.7

titre

0.71

151

1419

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

163

2.09

3.96

2.0

2.5

44.7

44.6

0.01

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

206

1552

1.34

3.92

2.5

1.4

3.6

3.9

g/l

1.34

135

1107

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

3.64

3.92

1.2

1.3

—

(3011412) CD3 cells [#/volume] in Blood

284

1.80

3.88

1.7

2.1

1.1

e9/l

0.04

159

(3020630) Protein [Mass/volume] in Serum or Plasma

385

3154

1.24

3.81

3.1

1.6

66.5

67.2

g/l

1.04

344

2834

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

491

1.60

3.80

1.3

0.6

0.4

nmol/l

0.30

396

(3004588) Protein electrophoresis panel - Serum or Plasma

337

2724

1.25

3.77

2.6

1.5

—

(1002224) Polysomnography panel

268

2108

1.29

3.75

1.1

—

(3005322) IgE [Units/volume] in Serum or Plasma

363

2962

1.24

3.73

1.3

144.0

225.4

u/ml

2.59

332

2752

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

2.64

3.72

1.4

2.0

1.2

mmol/l

0.58

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

368

3010

1.24

3.70

1.4

1.3

39.2

52.2

au/ml

0.56

136

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

399

3293

1.23

3.69

2.5

2.4

23.9

au/ml

0.00

181

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

567

1.54

3.66

1.3

261.7

291.0

pmol/l

0.62

417

(3025159) Blasts/100 leukocytes in Blood

381

3133

1.23

3.65

4.3

4.0

0.0

0.2

0.55

565

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

150

1091

1.39

3.60

2.0

2.4

175.9

183.3

0.52

135

1037

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

540

1.55

3.54

1.3

1.2

—

nmol/l

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

469

1.59

3.53

1.3

—

(1761482) Bacteria [#/volume] in Urine by Culture

139

1002

1.40

3.52

5.1

3.9

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

206

1.90

3.52

1.2

1.3

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

118

2.21

3.50

1.1

106.2

110.8

0.30

106

(3019309) Folate [Moles/volume] in Red Blood Cells

887

7881

1.15

3.49

1.7

1136.9

1162.8

nmol/l

0.38

683

5989

(3047189) Immunofixation for 24 hour Urine

132

2.13

3.44

2.6

1.2

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

140

1015

1.39

3.44

1.1

1.2

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

215

1.87

3.43

1.7

1.8

16.9

15.3

0.28

101

(3028626) Oxygen [Partial pressure] in Capillary blood

116

814

1.43

3.43

2.5

2.7

8.3

8.1

kpa

0.94

103

751

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

3.71

3.35

1.2

1.1

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

637

1.48

3.33

4.8

5.6

807.0

679.7

iu/ml

0.10

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

189

1444

1.32

3.32

2.6

1.4

10.1

10.4

g/l

0.41

152

1210

(3006653) Thiamine [Moles/volume] in Blood

232

1.82

3.32

1.2

1.3

137.5

137.3

nmol/l

0.01

232

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

485

1.55

3.31

2.3

1.7

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

470

1.56

3.28

1.2

1.3

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

633

5513

1.17

3.26

1.6

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

212

1.85

3.25

1.2

1.3

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

123

882

1.40

3.24

1.3

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

190

1459

1.31

3.23

2.6

1.4

3.1

3.0

g/l

0.36

140

1134

(3015235) Bicarbonate [Moles/volume] in Capillary blood

135

985

1.38

3.22

2.2

2.9

24.1

24.8

mmol/l

1.15

116

863

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

432

3647

1.20

3.21

1.8

1.9

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

481

1.55

3.20

1.3

—

(3020779) Urea [Moles/volume] in Serum or Plasma

398

3336

1.21

3.19

7.1

7.7

9.6

9.9

mmol/l

0.26

373

3177

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

478

4077

1.19

3.17

1.9

—

(3024869) Neuronal Ab [Presence] in Serum

2.54

3.12

1.0

1.1

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

201

1.85

3.11

1.2

1.8

5.0

4.7

nmol/l

0.04

161

(3010144) Erythrocytes [#/volume] in Synovial fluid

429

1.57

3.10

1.3

102341.3

119863.5

e6/l

0.09

291

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

108

764

1.42

3.09

1.7

1.6

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

153

1150

1.34

3.04

1.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

218

1.79

3.00

1.4

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

370

1.60

2.99

3.3

3.9

—

(21494890) Protein electrophoresis panel - 24 hour Urine

324

1.64

2.98

2.2

1.3

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

120

2.09

2.97

1.1

82.3

90.8

0.41

(3011985) Renin [Units/volume] in Plasma

604

1.46

2.97

1.6

1.4

42.0

63.0

mu/l

1.09

540

(3004119) Hemoglobin [Mass/volume] in Venous blood

302

2485

1.23

2.93

4.0

3.3

131.2

131.9

g/l

0.23

291

2411

(3017354) Segmented neutrophils/100 leukocytes in Blood

318

1.64

2.92

2.0

2.9

59.6

58.6

0.10

205

(3021879) Hepatitis B virus core Ab [Presence] in Serum

339

2824

1.21

2.92

1.4

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

169

1301

1.31

2.87

2.9

1.5

1.3

0.5

g/l

2.50

141

1117

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

159

1216

1.32

2.83

2.1

95.6

92.5

1.03

145

1126

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

116

2.07

2.82

1.1

89.5

93.9

0.15

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

466

4010

1.18

2.81

3.0

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

3.06

2.80

1.7

2.2

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

514

1.49

2.78

2.0

2.1

21.8

23.9

mg/l

0.19

124

(40758292) HTLV I+II Ab panel - Serum

3.23

2.77

1.3

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

130

969

1.35

2.76

2.1

1.9

190.4

201.1

pmol/l

0.55

124

918

(3000330) Specific gravity of Urine by Test strip

262

2140

1.24

2.75

4.1

3.2

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

460

1.51

2.71

1.3

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

218

1.75

2.71

1.5

1.7

7.8

9.8

ug/l

0.50

187

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

153

1.90

2.69

2.7

2.5

—

(3026389) Candida sp identified in Specimen by Organism specific culture

617

1.43

2.69

1.4

1.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

461

1.50

2.69

1.3

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

364

3079

1.20

2.69

1.2

167.7

140.8

iu/ml

0.54

131

1231

(3021387) Prolactin [Units/volume] in Serum or Plasma

174

1358

1.29

2.69

1.7

300.1

304.5

mu/l

0.06

162

1220

(3045414) Leukocytes [Presence] in Urine

250

2041

1.24

2.65

2.0

1.8

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

553

1.45

2.64

1.3

1.2

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

464

1.49

2.62

1.3

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

698

1.40

2.58

1.2

—

(3029937) Albumin [Presence] in Urine by Test strip

1262

11657

1.11

2.58

4.1

3.9

0.0

estimate

0.14

434

3738

(3021901) Oxygen saturation in Capillary blood

690

1.40

2.57

2.2

2.6

—

(4038314)

5.46

2.54

1.2

—

(3042517) Benzodiazepines panel - Urine

3.03

2.52

1.2

2.6

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

744

6678

1.13

2.52

1.7

1.8

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

300

0.43

2.50

12.2

17.1

1410.9

1405.8

nmol/l

0.01

291

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

122

1.97

2.49

1.3

130.5

143.8

nmol/l

0.12

(3032057) Clostridioides difficile [Presence] in Stool

2.20

2.47

1.7

1.9

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

109

808

1.36

2.44

2.8

3.0

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

218

1774

1.24

2.41

1.6

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

2.29

2.41

1.3

1.5

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

2.29

2.41

2.1

2.7

—

(21494755) Public health laboratory ask at order entry panel

538

4745

1.15

2.38

1.3

1.4

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.75

2.37

1.7

2.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

402

1.50

2.35

1.5

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

585

5198

1.14

2.33

1.7

1.6

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

705

1.37

2.30

1.2

5.8

4.5

u/ml

0.21

313

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

396

1.50

2.30

1.2

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

107

800

1.34

2.29

1.4

1.6

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

134

1035

1.30

2.29

2.2

2.5

3.7

3.5

g/l

0.40

128

974

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

487

1.44

2.28

1.3

1.4

—

33.7

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

2.46

2.27

10.2

9.0

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

691

1.37

2.25

1.1

121.5

116.7

0.79

628

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

171

1.76

2.24

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

718

1.36

2.22

1.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

659

1.37

2.21

1.6

1.2

20.5

28.7

u/l

0.78

570

(3020961) Endomysium IgA Ab [Titer] in Serum

259

2167

1.20

2.21

1.1

255.7

197.1

titre

—

(3036489) Thrombin time

188

1522

1.24

2.20

1.8

1.9

21.6

21.1

0.38

152

1304

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.13

2.18

1.0

1.1

—

(3036603) Volume of Urine

257

1.60

2.17

1.7

1.5

1786.7

2004.2

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

105

792

1.33

2.14

1.6

1.4

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

157

1251

1.26

2.12

1.2

1.1

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

257

2161

1.20

2.09

1.7

1.6

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

244

1.60

2.09

1.8

1.7

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

726

1.34

2.09

1.2

2.0

3.9

u/ml

1.25

235

(3014765) Yersinia sp identified in Stool by Organism specific culture

158

1263

1.26

2.09

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

259

2185

1.19

2.04

1.3

1.4

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

233

1948

1.20

2.03

1.5

1.6

58.0

16.0

u/ml

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

373

3246

1.16

2.02

4.0

3.0

1.2

mmol/l

0.39

335

2758

(3045424) Erythrocytes [Presence] in Urine

748

1.33

2.02

1.6

1.5

—

(42529406) Shigella sp [Presence] in Stool by Culture

158

1272

1.25

1.98

1.2

1.1

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

173

1411

1.23

1.94

1.9

1.7

0.2

g/l

0.23

162

1329

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

157

1.72

1.92

1.9

1.4

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

157

1.72

1.92

1.9

1.4

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

157

1.72

1.92

1.9

1.4

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

157

1.72

1.92

1.9

1.4

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

215

1795

1.21

1.92

4.1

3.7

48.6

48.7

0.02

215

1769

(3047007) Chlamydophila sp Ab [Presence] in Serum

642

1.34

1.91

1.3

1.2

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

152

1226

1.25

1.89

2.7

1.4

38.0

g/l

0.01

123

1041

(44813793)

317

1.49

1.85

1.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

140

1123

1.25

1.84

2.2

1.9

9065.6

4871.2

u/l

0.41

446

(3017704) Immunofixation for Urine

190

1.64

1.83

2.2

1.2

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

148

1195

1.25

1.83

4.4

1.5

60.9

38.6

mg/l

0.36

122

953

(3024354) Oxygen [Partial pressure] in Venous blood

343

2992

1.16

1.83

3.2

3.1

4.7

4.6

kpa

0.35

337

2898

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

682

1.33

1.83

1.1

7.7

16.8

au/ml

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

115

1.83

1.82

2.1

1.5

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

144

1161

1.25

1.81

4.2

1.5

8.4

2.0

ratio

—

117

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

175

1442

1.22

1.80

1.8

1.6

1.2

g/l

0.05

164

1353

(3034860) Kappa light chains.free [Mass/volume] in Serum

148

1198

1.24

1.80

4.4

1.6

54.1

45.3

mg/l

0.32

121

962

(3025130) Human papilloma virus identified in Specimen

563

1.35

1.80

1.7

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

429

1.40

1.76

1.2

1.5

31.6

32.0

0.03

265

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

224

1.57

1.75

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

687

1.32

1.75

1.0

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

162

1.67

1.74

1.0

1.2

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

249

1.53

1.72

1.2

1.4

—

(21494814) CD8 cells/100 lymphocytes in Specimen

110

1.82

1.72

1.5

1.8

—

(3010503) CD19 cells [#/volume] in Blood

178

1.63

1.72

1.7

2.3

0.1

e9/l

0.46

172

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

186

1.62

1.71

2.1

2.4

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

586

1.34

1.70

1.5

1.6

59.0

57.4

0.12

365

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

743

1.30

1.70

1.3

1.4

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

1.95

1.69

1.6

1.8

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

156

1.67

1.68

1.2

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

156

1.67

1.68

1.2

1.3

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

544

1.35

1.68

1.3

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

111

1.80

1.68

1.2

1.1

—

(3023183) Ammonium ion [Moles/volume] in Plasma

106

834

1.28

1.66

2.1

2.8

29.5

34.8

umol/l

2.10

718

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

494

1.36

1.65

1.3

1.4

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

427

3815

1.13

1.63

2.4

6.7

7.9

ug/l

0.41

375

3355

(40760888) Immunoglobulin light chains.free panel - Serum

111

882

1.26

1.61

4.3

1.5

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

622

5680

1.11

1.61

1.9

1.8

1.4

1.5

0.58

552

5029

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

767

1.28

1.61

1.6

1.4

—

(3000475) Leukocytes [#/volume] in Synovial fluid

139

1134

1.23

1.61

1.5

1.6

12645.8

11298.3

e6/l

0.14

103

813

(3004616) Nuclear Ab [Presence] in Serum

601

1.32

1.60

1.3

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

125

1010

1.24

1.58

2.8

1.5

mg/l

0.18

114

917

(3027974) Hepatitis B virus e Ag [Presence] in Serum

3.00

1.58

1.8

1.6

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

3.00

1.58

1.8

1.7

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

114

1.76

1.56

2.1

1.5

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

114

1.76

1.56

2.1

1.5

—

(3029396) Erythrocyte agglutination [Presence] in Blood

2.11

1.55

2.4

3.2

—

(3050794) Legionella sp Ab [Presence] in Serum

2.43

1.53

1.0

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

365

1.40

1.52

1.7

1.4

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

340

1.42

1.52

1.4

1.2

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

226

1942

1.17

1.51

1.9

38.6

39.4

u/l

0.28

200

1706

(3043409) Potassium [Moles/volume] in Arterial blood

146

1206

1.22

1.51

4.1

4.4

3.8

3.9

mmol/l

0.93

139

1138

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

2.86

1.50

10.0

1.9

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

258

1.48

1.50

1.2

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

2.37

1.45

3.1

1.7

—

(40767503) Oxygen content in Capillary blood by calculation

103

824

1.25

1.45

1.9

2.4

17.2

16.6

0.77

434

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

629

1.29

1.44

1.3

1.4

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

153

1277

1.20

1.44

1.3

1.4

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.73

1.43

1.0

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

630

1.29

1.43

1.2

1.3

6.8

7.6

mmol/l

1.37

466

(3014271) Vancomycin [Susceptibility]

196

1.53

1.42

2.9

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

120

980

1.23

1.41

1.4

1.3

8.7

25.1

e6/l

1.34

759

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

747

1.26

1.40

1.3

1.4

—

13.8

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

120

981

1.23

1.40

1.4

1704.9

1159.0

e6/l

0.21

808

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

467

1.33

1.38

1.3

1.5

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

339

1.39

1.37

3.8

3.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

127

1.66

1.36

1.0

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

2.94

1.36

2.4

4.5

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

1.75

1.34

1.2

0.4

0.7

umol/24h

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

682

1.27

1.32

1.1

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

197

1697

1.17

1.32

1.6

1.5

g/l

0.00

163

1456

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

612

1.28

1.31

1.0

1.1

4.0

3.6

u/ml

0.10

295

(3044290) Cell count panel - Cerebral spinal fluid

108

882

1.23

1.29

1.3

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

218

1.47

1.27

1.7

1.6

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

139

1166

1.20

1.27

2.9

1.5

0.1

0.0

g/l

0.41

129

1063

(4306422)

722

1.25

1.27

1.2

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

758

1.24

1.27

1.5

1.6

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.22

1.24

1.0

—

(3025549) Creatine [Moles/time] in 24 hour Urine

2.22

1.24

1.6

1.4

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

123

1.63

1.23

1.1

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

779

1.24

1.23

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

282

2508

1.13

1.22

1.7

—

(4024509)

434

1.32

1.21

1.8

1.5

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

461

1.30

1.20

1.3

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

331

1.36

1.20

1.8

1.5

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

710

1.24

1.20

1.0

1.1

0.9

2.0

u/ml

1.23

163

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

211

1844

1.15

1.19

2.8

0.7

0.6

0.49

203

1752

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

384

1.33

1.18

1.2

49.0

40.6

u/ml

—

(4015189)

125

1.60

1.17

1.8

2.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

290

1.38

1.17

1.6

1.3

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

290

1.38

1.17

1.6

1.3

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

290

1.38

1.17

1.6

1.3

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

736

0.77

1.16

1.5

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

150

1281

1.18

1.15

1.2

1.3

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

126

1.59

1.14

3.5

2.7

—

(3023410) Appearance of Cerebral spinal fluid

422

1.31

1.13

1.8

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

676

0.77

1.12

1.4

—

(3044009) aPTT.lupus sensitive (LA screen)

2.00

1.12

1.3

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

582

1.26

1.12

1.1

1.4

1.5

g/l

0.77

510

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

353

1.33

1.11

1.1

1.2

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

675

0.77

1.11

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

675

0.77

1.11

1.4

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

224

1978

1.14

1.11

1.3

0.6

0.8

u/ml

0.24

184

(3008898) HLA-B27 [Presence]

190

1659

1.15

1.10

1.1

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

159

1370

1.17

1.10

1.3

9.0

44.0

u/ml

3.81

(3043238) Trisomy 21 risk [Likelihood] in Fetus

584

0.75

1.10

1.5

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

736

1.23

1.10

1.2

238.0

278.2

u/ml

0.92

472

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

674

0.77

1.10

1.4

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

285

1.37

1.10

1.2

1.1

ratio

—

102

(3030313) Adrenal Ab [Titer] in Serum

2.38

1.09

1.2

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

451

1.29

1.09

1.5

1.3

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

126

1067

1.19

1.08

2.9

1.5

0.0

g/l

0.00

117

981

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

128

1.56

1.08

1.1

—

(3017569) Oxygen content in Arterial blood

206

0.58

1.08

1.4

2.0

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

1.87

1.07

3.6

1.4

34.8

102.9

u/l

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

203

1.43

1.05

1.3

1.5

8.6

8.2

mmol/l

0.32

120

(3020891) Body temperature

183

1603

1.15

1.03

4.5

4.8

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

2.27

1.03

1.2

1.0

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

2.27

1.03

1.2

1.1

—

(3014051) Protein [Presence] in Urine by Test strip

120

1018

1.18

1.02

2.3

2.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

179

1.45

1.02

1.3

1.4

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

671

1.23

1.02

1.5

1.6

—

(44790047)

386

1.30

1.00

1.6

1.4

—

(44790048)

386

1.30

1.00

1.6

1.4

—

(44806118)

386

1.30

1.00

1.6

1.4

—

(44790049)

386

1.30

1.00

1.6

1.4

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

127

1085

1.17

1.00

2.9

1.5

0.0

g/l

0.00

117

984

(3006184) Hemoglobin [Mass/volume] in Capillary blood

109

919

1.19

1.00

1.8

2.1

135.2

131.9

g/l

0.77

664

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.88

1.00

1.0

1.3

—

(3007566) Smooth muscle Ab [Titer] in Serum

145

1253

1.16

0.99

1.2

153.3

128.5

titre

0.17

112

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

206

1825

1.13

0.99

3.8

4.1

24.3

mmol/l

0.04

182

1617

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

107

1.59

0.99

1.1

2.3

—

2558.5

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

115

1.57

0.99

2.8

2.6

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

115

1.57

0.99

2.8

2.6

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

145

1254

1.16

0.99

1.3

264.4

218.0

miu/ml

0.72

596

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

244

2186

1.12

0.98

2.0

1.8

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

674

1.22

0.98

1.4

1.5

113.9

113.4

u/ml

0.02

137

(44806071)

1.80

0.98

1.0

1.1

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

173

1517

1.14

0.98

1.9

1.8

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

224

1.39

0.96

2.5

2.1

49.0

228.7

ug/min

—

(3044242) Glucose [Moles/volume] in Arterial blood

198

0.61

0.95

1.6

1.8

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

769

1.20

0.94

3.0

3.7

56.5

57.2

0.22

769

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

524

1.24

0.94

1.1

95.6

96.5

0.10

497

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

225

1.38

0.94

1.7

2.2

737.2

774.4

e6/l

0.09

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

286

1.33

0.92

1.1

9.9

9.1

iu/ml

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

150

1.47

0.92

1.8

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

150

1.47

0.92

1.8

1.5

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

127

1096

1.16

0.91

1.6

1.9

5.4

4.4

iu/l

0.37

416

(3047352) Trisomy 18 risk [Likelihood] in Fetus

565

0.78

0.91

1.5

1.4

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

287

1.33

0.91

1.2

1.0

1.3

8.6

nmol/l

—

(3007916) DNA double strand Ab [Titer] in Serum

1.75

0.90

1.5

1.3

—

95.3

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

195

1737

1.13

0.89

1.9

1.8

—

(3005033) Fetal Nuchal fold Thickness US

563

0.78

0.89

1.5

1.4

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

202

1.39

0.89

1.3

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

177

1.41

0.88

1.3

1.4

—

(3019174) dRVVT (LA screen)

1.86

0.87

1.1

1.2

—

(4212803)

2.00

0.87

1.0

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

360

1.28

0.86

1.2

2.7

7.1

u/ml

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

787

1.18

0.85

1.3

1.2

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.82

0.85

1.1

1.2

1.8

1.7

umol/24h

—

(3041354) Potassium [Moles/volume] in Venous blood

451

1.24

0.84

2.9

2.1

4.0

4.1

mmol/l

1.32

444

(3043410) Blood group antigens tested for on Red Blood Cells

1.59

0.84

3.1

1.3

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.59

0.84

1.5

1.6

105.0

124.6

ng/l

0.39

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.78

0.84

1.6

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

1.78

0.84

1.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

706

1.19

0.84

3.7

3.1

0.8

nmol/l

0.38

537

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

371

1.27

0.83

2.3

2.4

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.76

0.83

1.8

2.4

—

(3006270) Folate [Moles/volume] in Blood

398

1.26

0.83

1.1

1.2

347.5

374.1

nmol/l

0.39

345

(4027681)

257

1.32

0.82

1.2

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

114

985

1.16

0.82

1.2

3.7

3.9

mmol/l

0.93

103

916

(1616796) Gas panel - Central venous blood

100

855

1.17

0.82

2.8

3.6

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

390

1.26

0.82

1.8

2.0

7.7

7.0

umol/l

0.08

270

(3036670) Protein [Mass/volume] in Synovial fluid

138

1.45

0.81

1.2

36.7

38.5

g/l

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

117

1015

1.16

0.81

1.2

1.0

4.8

u/ml

—

(3019977) pH of Arterial blood

215

1.35

0.80

2.3

2.4

7.4

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

181

1.38

0.79

2.4

4.5

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

339

1.27

0.78

1.0

1.2

33.3

37.9

mg/l

0.71

286

(3002619) Bacteria identified in Specimen by Culture

1.59

0.78

1.0

1.3

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

584

1.20

0.77

1.0

1.1

1.5

3.6

u/ml

2.20

220

(40768806) Pleura Pathology biopsy report

234

1.33

0.77

1.4

1.5

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

548

1.21

0.76

1.6

1.5

—

(3012441) Differential panel - Pleural fluid

261

1.30

0.76

1.4

1.5

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

233

0.69

0.76

1.1

1.4

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

440

1.23

0.75

3.0

2.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.70

0.75

1.0

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.70

0.75

1.0

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.70

0.75

1.0

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.57

0.74

1.6

1.4

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

2.08

0.74

1.0

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

2.08

0.74

1.0

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

459

1.22

0.74

1.2

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

661

1.18

0.74

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.84

0.73

1.0

—

(3037556) Urate [Mass/volume] in Serum or Plasma

133

1.43

0.73

1.6

1.2

—

(3035285) Chloride [Moles/volume] in Venous blood

451

1.22

0.73

3.0

2.1

105.4

105.7

mmol/l

0.24

444

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

708

1.17

0.73

1.7

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

2.00

0.72

1.0

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

159

1.39

0.72

1.3

1.1

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

271

2943

0.92

0.72

1.4

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

246

1.30

0.71

1.5

1.3

—

(3000060) B lymphocytes [#/volume] in Blood

1.58

0.71

1.9

2.0

358.3

157.2

e6/l

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

127

1121

1.14

0.71

1.2

469.3

497.7

mg/l

0.53

117

1058

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

282

1.28

0.70

1.2

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

300

1.27

0.70

1.2

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

126

1.43

0.70

1.3

1.5

0.3

0.4

ug/l

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

117

1029

1.14

0.70

1.2

47.0

41.7

u/ml

0.09

111

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.53

0.68

1.0

1.2

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

141

1257

1.12

0.68

1.3

4.1

5.6

u/ml

0.35

200

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.67

0.68

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

257

1.29

0.68

1.2

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

123

1088

1.13

0.68

1.8

1.7

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

630

1.18

0.68

1.0

1.1

2.0

2.7

u/ml

0.48

238

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

302

1.26

0.67

1.2

1.3

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

0.54

0.67

2.2

2.1

15.7

17.6

umol/l

—

(3036071) Salmonella sp Ab [Titer] in Serum

153

1.37

0.66

1.0

1.1

—

(3048879) Bone marrow aspiration report

1.54

0.65

1.7

1.5

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.59

0.65

1.0

1.1

—

(3024928) Oxygen saturation in Venous blood

867

1.14

0.64

3.1

3.5

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

189

0.69

0.63

1.0

1.1

—

3.7

—

(4146454)

487

1.19

0.63

3.2

2.7

—

(44806420)

112

1.43

0.63

1.9

2.4

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.50

0.63

1.5

1.4

—

(3015183) Erythrocyte sedimentation rate

225

1.29

0.63

1.2

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

1.52

0.62

1.1

1.2

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

103

0.58

0.62

1.5

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

114

1282

0.89

0.62

1.4

1.5

—

(3034426) Prothrombin time (PT)

176

0.68

0.61

1.1

1.3

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

170

1544

1.10

0.61

1.4

1.5

—

(3000093) Morphology [Interpretation] in Blood Narrative

334

1.23

0.61

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

156

1.35

0.61

1.8

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

325

1.23

0.60

1.0

1.1

251.2

257.6

mg/l

0.12

291

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

316

1.24

0.60

1.1

—

(3023419) Bacteria identified in Sputum by Culture

518

1.18

0.60

3.1

2.5

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.54

0.59

1.1

1.0

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

771

1.14

0.58

1.3

1.6

0.5

0.8

g/l

3.10

593

(3034770) Mitochondria Ab [Titer] in Serum

140

1263

1.11

0.58

1.2

895.0

1247.9

titre

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

345

1.22

0.58

1.1

1.2

1.9

2.1

mmol/l

0.99

326

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.72

0.57

1.7

1.5

67.0

45.1

umol/l

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

135

1217

1.11

0.57

2.1

2.0

10.7

mg/l

0.03

127

1124

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.48

0.57

1.1

1.2

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

172

1571

1.10

0.57

1.5

1.6

84.0

326.9

titre

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

211

1.28

0.57

1.0

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

736

1.14

0.56

1.3

1.5

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

137

1239

1.11

0.55

1.3

2.1

5.1

u/ml

0.61

123

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.62

0.55

2.3

2.4

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

107

1.40

0.55

1.3

1.4

70.0

71.5

0.11

101

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

533

1.17

0.54

1.5

1.7

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

1.58

0.54

1.2

1.1

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

1.58

0.54

1.0

1.1

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.54

0.53

1.2

1.1

—

(4034850)

172

1582

1.09

0.51

11.7

9.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

281

0.78

0.51

1.1

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

197

1.27

0.51

2.0

2.3

181.7

148.6

umol/l

—

106

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

242

1.24

0.50

1.1

1.2

—

(3012501) Base excess in Blood by calculation

848

1.12

0.50

3.1

4.1

2.7

2.5

mmol/l

0.35

557

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

563

0.85

0.50

1.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

280

0.78

0.49

1.1

—

(3045716) Anion gap in Serum or Plasma

198

1.26

0.49

3.6

2.1

9.6

9.3

mmol/l

0.10

152

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

455

1.17

0.48

1.4

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

280

1.22

0.48

1.6

1.5

186223.7

56294.6

e6/l

0.45

170

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

420

4411

0.95

0.48

1.8

—

(3020491) Glucose [Moles/volume] in Blood

335

1.20

0.48

1.7

2.2

6.6

6.7

mmol/l

0.04

224

(3020650) Glucose [Presence] in Urine

109

0.64

0.48

1.6

1.5

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

128

1.33

0.47

1.8

1.3

27.7

33.7

0.29

(3028717) Thiamine [Mass/volume] in Blood

1.49

0.47

1.0

1.2

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

277

0.79

0.46

1.1

1.2

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

123

1122

1.10

0.45

2.0

2.4

89.5

109.2

ug/min

0.24

674

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

855

1.11

0.45

1.1

1.2

—

(3023199) Leukocytes [#/volume] in Pleural fluid

320

1.19

0.44

1.5

4409.0

2085.3

e6/l

0.34

238

(3010421) pH of Blood

112

1019

1.10

0.44

3.0

4.0

7.4

0.61

833

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.37

0.44

1.0

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

0.66

0.42

7.0

7.3

—

(3009871) Measles virus Ab [Titer] in Serum

162

0.74

0.42

1.8

1.7

—

(3029075) Extractable nuclear Ab panel - Serum

122

1.31

0.42

1.2

1.0

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

1.56

0.42

1.2

1.3

—

2.4

—

(3044927) Protein electrophoresis panel - Urine

425

1.15

0.41

1.7

1.2

—

(3051611) Lipemic interference index of Serum or Plasma

369

1.17

0.41

2.3

3.4

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.43

0.41

1.1

1.3

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

(3011325) HIV 1+2 Ab [Presence] in Serum

0.00

0.41

0.0

1.1

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

105

1.33

0.41

1.1

1.2

636.4

278.2

pmol/l

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

520

1.14

0.40

1.0

1.1

0.3

u/ml

0.01

110

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

370

1.16

0.40

1.1

1.3

9.7

11.7

mmol/l

—

(3022621) pH of Urine by Test strip

307

2917

1.06

0.40

2.8

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

106

1.32

0.39

1.3

1.4

535.7

427.4

mu/l

0.21

100

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

377

0.85

0.38

1.2

90.0

218.0

titre

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

112

0.71

0.37

11.6

7.3

—

(3020874) Milk IgE Ab [Units/volume] in Serum

271

1.18

0.37

1.0

0.6

2.9

u/ml

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

161

1.24

0.37

1.2

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

782

1.10

0.36

1.0

1.1

3.2

4.2

u/ml

0.50

381

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

235

1.19

0.36

1.6

1.7

—

(3013293) Extractable nuclear Ab [Presence] in Serum

0.65

0.35

2.0

1.7

—

(3021788) Differential panel - Synovial fluid

861

1.09

0.35

1.3

1.5

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

123

0.73

0.35

1.0

1.1

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

155

1450

1.07

0.35

2.1

2.4

346.4

684.5

ug/l

1.09

145

1354

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.36

0.34

1.0

1.2

—

(40761536) Microorganisms panel - Urine sediment

364

3495

1.04

0.33

4.0

3.8

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

321

1.15

0.33

1.9

1.6

70.8

69.3

umol/l

—

(3019832) Treponema pallidum Ab [Presence] in Serum

326

3128

1.04

0.32

1.6

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

886

1.09

0.31

1.1

0.4

1.3

u/ml

2.35

330

(3009466) Valproate [Moles/volume] in Serum or Plasma

685

0.90

0.31

4.5

5.2

367.8

365.7

umol/l

0.04

592

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

380

1.13

0.31

1.0

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

294

0.85

0.31

1.4

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

240

0.83

0.30

6.6

6.0

32.1

631.7

u/ml

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.27

0.30

1.0

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

1.29

0.30

1.8

2.6

6.6

7.5

mmol/l

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

271

0.85

0.29

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

755

1.09

0.29

1.0

1.1

0.6

0.9

u/ml

0.32

292

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

377

0.87

0.29

1.2

—

119.0

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.23

0.29

1.0

1.2

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

115

1075

1.07

0.28

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

826

0.92

0.28

1.3

1.4

—

(3045788) Cell count panel - Pleural fluid

242

1.16

0.28

1.6

—

(3000034) Microalbumin [Mass/volume] in Urine

470

1.11

0.27

3.2

2.9

34.1

44.2

mg/l

0.24

337

(3039443) Prostate specific Ag panel - Serum or Plasma

895

1.07

0.26

1.5

1.6

—

(3028707) Methadone [Presence] in Urine by Screen method

644

1.09

0.26

2.6

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

644

1.09

0.26

1.2

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

150

1.20

0.26

1.7

2.0

6.5

9.6

mg/l

—

121

(3032773) Endomysium IgG Ab [Titer] in Serum

386

1.11

0.26

1.0

1.1

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

761

1.08

0.25

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

761

1.08

0.25

1.3

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

142

1.20

0.24

1.4

2.0

230.5

177.0

0.63

133

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

168

1601

1.05

0.24

2.1

1.8

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

1.17

0.24

1.0

1.1

5.0

7.5

mg/g

—

(4133840)

126

0.79

0.24

1.2

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

941

0.93

0.24

3.4

23.6

25.6

mg/l

0.28

587

(3024139) IgG subclass 3 [Mass/volume] in Serum

504

1.09

0.23

1.2

1.3

0.4

g/l

0.11

358

(3027135) IgG subclass 1 [Mass/volume] in Serum

504

1.09

0.23

1.2

1.3

6.1

6.7

g/l

1.11

358

(3001556) Androgen free Index in Serum or Plasma

1.32

0.23

3.2

1.2

—

(4198724)

179

0.84

0.23

3.1

2.8

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

505

1.09

0.22

1.2

1.3

3.0

g/l

0.09

357

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

168

0.83

0.22

1.4

—

1698295.8

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.25

0.22

1.0

1.1

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

337

0.89

0.22

1.0

40.7

45.6

ng/l

0.31

227

(3003181) Sodium [Moles/volume] in Urine

699

1.07

0.22

1.1

1.4

57.3

64.3

mmol/l

0.88

559

(3042733) HLA Ab [Presence] in Serum

146

0.82

0.22

5.6

5.2

—

(3016750) Collection duration of Urine

263

0.87

0.22

1.7

2.2

534.2

495.9

min

0.86

199

(3024471) HLA-A [Type]

135

0.81

0.22

1.0

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

468

1.09

0.21

1.0

1.1

—

63.1

—

(3034614) HLA Ag [Interpretation]

0.00

0.21

0.0

1.1

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

0.00

0.21

0.0

1.1

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

0.00

0.21

0.0

1.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.21

0.0

1.2

—

(3012565) Volume of 24 hour Urine

209

0.86

0.21

2.8

2.0

1823.9

2026.5

0.42

184

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3046861) Legionella sp Ag [Presence] in Urine

0.00

0.21

0.0

1.0

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.1

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.21

0.0

1.0

—

(3024932) HLA-DR beta [Type]

134

0.82

0.20

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

117

1.20

0.20

1.4

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

259

1.12

0.20

1.3

1.4

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

111

0.81

0.20

1.0

1.1

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

334

0.90

0.20

1.0

848.4

719.8

ng/l

0.87

222

(3003129) Base excess in Capillary blood by calculation

115

0.78

0.20

1.8

1.5

-2.8

0.5

mmol/l

—

109

(3006922) Hepatitis E virus Ab [Presence] in Serum

302

0.89

0.19

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

133

0.83

0.19

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

133

0.83

0.19

1.2

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

133

0.83

0.19

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

133

0.83

0.19

1.2

1.1

—

(3044941) Cell count panel - Synovial fluid

753

1.06

0.19

1.3

1.4

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.22

0.19

1.1

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

356

1.10

0.19

1.4

1.5

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

1.13

0.18

3.3

6.6

56.0

43.6

ug/min

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

164

1577

1.04

0.18

1.5

1.4

—

(4062490)

502

1.08

0.18

1.3

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

248

0.89

0.18

1.2

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

121

0.83

0.18

1.0

1.1

—

(4268621)

493

1.08

0.17

2.1

2.3

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

110

1.18

0.17

1.0

1.1

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

330

0.91

0.17

1.0

331.4

327.3

ng/l

0.03

228

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

454

0.92

0.16

1.3

1.5

—

(3023383) Lactate [Moles/volume] in Pleural fluid

1.13

0.16

1.1

1.4

5.8

3.2

mmol/l

—

(3023511) Choriogonadotropin [Units/volume] in Urine

613

1.06

0.15

1.3

1.2

—

(3042631) Mycobacterium sp identified in Specimen

467

1.07

0.15

2.1

3.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.21

0.15

1.0

1.1

—

(3051651) Icteric interference index of Serum or Plasma

197

1.12

0.15

2.5

3.8

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

102

1.18

0.15

1.8

2.5

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

389

0.92

0.14

1.1

1.3

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

0.80

0.14

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

223

0.90

0.14

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

150

1.13

0.14

1.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.19

0.14

1.0

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

266

1.09

0.14

1.0

0.6

0.8

u/ml

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

941

1.04

0.13

1.5

1.8

1.0

0.8

nmol/l

1.36

788

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

180

1.11

0.13

1.1

1.3

—

(3033799) Differential panel - Peritoneal fluid

1.17

0.13

2.0

2.1

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

113

1.15

0.13

1.1

0.3

1.6

u/ml

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

374

1.07

0.13

1.3

1.4

65.2

157.6

pmol/l

0.53

107

(3014148) Varicella zoster virus Ab [Titer] in Serum

519

0.94

0.12

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

127

0.87

0.12

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

326

1.07

0.12

2.0

2.1

2.4

1.8

u/field

0.26

134

(3028433) Virus identified in Specimen by Culture

143

1.12

0.11

1.2

1.1

—

(3011648) Oxygen content in Venous blood

332

0.93

0.11

2.2

2.3

11.1

11.2

0.04

332

(44816559) Phosphatidylethanol [Mass/volume] in Blood

868

1.04

0.11

1.8

1.3

—

(3022689) Creatine [Moles/volume] in Urine

154

1.10

0.10

1.9

1.4

—

(3014891) Appearance of Pleural fluid

1.11

0.09

1.0

1.6

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

148

1444

1.03

0.09

1.6

26.9

0.2

iu/ml

0.75

290

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.06

0.09

2.2

2.4

0.6

u/field

—

(40768446) Kidney Pathology biopsy report

174

1.09

0.09

1.3

1.6

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

124

0.89

0.09

9.6

7.2

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.03

0.08

1.0

1.2

—

(3008536) Aspergillus sp Ab [Presence] in Serum

0.82

0.08

2.0

1.7

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.82

0.08

3.8

4.6

—

(3052592) Norovirus Ag [Presence] in Stool

1.03

0.07

2.1

1.3

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

0.86

0.07

1.7

1.3

25.3

31.7

—

(3006462) Nitrate [Presence] in Urine

215

0.93

0.07

2.8

3.0

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

122

0.90

0.07

1.1

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

206

1.07

0.07

1.6

1.4

12.5

12.6

u/l

0.03

198

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

214

0.93

0.07

1.3

1.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.12

0.06

1.2

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

128

1.09

0.06

1.4

1.2

—

(3035880) pH of Pleural fluid

142

0.92

0.06

1.4

1.3

—

(3027008) Opiates [Presence] in Urine

148

1454

1.02

0.06

1.8

1.9

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

182

1792

1.02

0.06

1.6

1.7

2.6

4.0

mg/l

1.94

131

1256

(3016879) Cocaine [Presence] in Urine

137

1345

1.02

0.06

1.9

2.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

396

0.96

0.06

1.2

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

345

0.96

0.06

1.1

1.3

0.9

1.1

u/ml

0.08

156

(3039162) Centromere protein B Ab [Units/volume] in Serum

607

0.97

0.05

1.2

1.3

78.0

46.9

u/ml

—

(3000764) Benzodiazepines [Presence] in Urine

147

1447

1.02

0.05

1.9

2.0

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

120

0.92

0.05

1.3

1.1

—

(3040151) Glucose [Moles/volume] in Capillary blood

444

0.97

0.04

7.8

21.5

6.4

7.4

mmol/l

1.59

365

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

258

1.05

0.04

1.4

1.5

3.5

5.6

u/l

0.59

111

(40759836) Histone Ab [Presence] in Serum by Immunoblot

367

1.04

0.04

1.2

—

(3028300) Cannabinoids [Presence] in Urine

148

1460

1.01

0.04

1.9

2.0

—

(1761868) Lipid panel - Serum or Plasma

1730

17345

1.00

0.04

2.9

2.8

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

368

1.03

0.04

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

368

1.03

0.04

1.2

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

200

1.05

0.03

1.2

1.7

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

191

1.05

0.03

1.1

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

211

1.04

0.03

1.2

1.1

20.8

20.0

u/l

0.03

152

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

118

0.93

0.02

1.1

—

(3027944) Amphetamines [Presence] in Urine

141

1424

0.99

0.02

1.9

2.0

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

371

1.02

0.02

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

371

1.02

0.02

1.2

—

(3051593) INR in Capillary blood by Coagulation assay

198

0.96

0.02

9.7

8.5

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

114

1129

1.01

0.02

2.0

2.1

—

(4211845)

232

1.03

0.02

2.5

2.9

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

268

0.97

0.02

1.0

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

282

1.03

0.02

1.2

1.3

—

66.4

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

372

1.02

0.01

1.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

153

1.05

0.01

1.4

1.5

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

213

1.03

0.01

1.3

1.2

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

413

1.02

0.01

1.0

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.06

0.01

1.2

1.5

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

106

0.94

0.01

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

136

0.96

0.00

1.1

1.3

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

176

0.97

0.00

1.1

6.8

97.7

59.9

mg/l

1.57

122

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

184

1.03

0.00

1.1

—

(3011288) Drugs identified in Urine by Screen method

956

0.99

0.00

2.8

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.02

0.00

1.0

1.2

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

235

0.98

0.00

1.0

1.1

0.9

1.1

u/l

3.32

111

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

602

1.00

0.00

1.3

1.5

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

732

1.00

0.00

1.0

1.1

24.5

14111.9

iu/ml

0.55

169

(3001964) Herpes simplex virus Ag [Presence] in Specimen

106

1.04

0.00

1.5

1.4

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

156

1.03

0.00

1.4

1.1

—

(3035933) Granulocytes/100 leukocytes in Blood

107

1.03

0.00

1.2

1.7

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

204

0.98

0.00

1.1

1129.1

1538.5

miu/ml

0.87

204

(3000012) Reticulocyte production index

206

1.02

0.00

1.3

1.4

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

244

0.98

0.00

1.0

1.1

17.2

20.4

u/l

0.25

205

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

436

1.01

0.00

1.1

55.1

62.3

u/l

0.62

287

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

233

0.99

0.00

1.1

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

486

1.01

0.00

1.0

1.1

—

2.7

—

(3004775) Volume in Urine collected for unspecified duration

373

0.99

0.00

1.8

2.4

749.0

626.8

0.81

256

(3008295) Osmolality of Serum or Plasma

397

1.01

0.00

1.4

281.9

279.2

mosm/kgh2o

0.42

302

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.01

0.00

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

151

0.99

0.00

1.2

1.5

8.0

8.8

ug/l

0.49

151

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

171

0.99

0.00

1.0

3.0

—

(3004451) EKG impression Narrative

209

1.00

0.00

1.2

1.3

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

211

1.00

0.00

1.9

1.7

2.9

3.3

u/field

0.07

149

(3024263) Appearance of Synovial fluid

251

1.00

0.00

1.5

1.6

—

(3003740) Influenza virus B Ag [Presence] in Specimen

689

1.00

0.00

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

691

1.00

0.00

1.1

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.00

0.0

1.0

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.0

1.3

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.02

0.00

1.0

1.1

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.0

1.0

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(3000285) Sodium [Moles/volume] in Blood

1.02

0.00

1.7

1.1

—

(3052851) Hemolysis interference index of Serum or Plasma

117

1170

1.00

0.00

2.4

3.1

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

0.0

1.2

—

(3005011) Chlamydia sp Ab [Titer] in Serum

0.95

0.00

1.6

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.0

1.1

—

1334.3

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.00

0.0

2.3

—

(3041806) Other cells [#/volume] in Blood by Manual count

0.98

0.00

1.3

1.6

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

0.00

0.0

1.1

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.00

0.0

1.6

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

0.0

1.3

—

(3044007) Cell count panel - Peritoneal fluid

0.91

0.00

1.1

2.4

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

0.0

4.0

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

0.00

0.0

1.4

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

0.0

1.0

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.0

8.6

—

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

0.0

1.3

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

0.0

1.3

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

0.0

1.0

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

0.00

0.0

2.6

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.95

0.00

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.88

0.00

1.8

1.2

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

0.0

1.0

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

0.0

1.7

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_LIPO_SKIN_TRUNK_EXALLC – Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints